# EDGAR Filing Document

**Accession Number:** 0001209466
**File Stem:** 0001209466-26-000432
**Filing Date:** 2026-3
**Character Count:** 146224
**Document Hash:** bb3da41da09e45757f157960c4b065f3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209466-26-000432.hdr.sgml**: 20260330

**ACCESSION NUMBER**: 0001209466-26-000432

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260131

**FILED AS OF DATE**: 20260330

**DATE AS OF CHANGE**: 20260330

**PERIOD START**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVESCO EXCHANGE-TRADED FUND TRUST
- **CENTRAL INDEX KEY:** 0001209466

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21265
- **FILM NUMBER:** 26811053

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POWERSHARES EXCHANGE TRADED FUND TRUST
- **DATE OF NAME CHANGE:** 20021210

## Series and Classes Contracts Data

### Invesco Dorsey Wright Healthcare Momentum ETF (Series ID: S000013104)

| Class ID   | Class Name                                    | Ticker Symbol   |
|:---|:---|:---|
| C000035320 | Invesco Dorsey Wright Healthcare Momentum ETF | PTH             |

## Nport-Ex

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.96%** | **Common Stocks & Other Equity Interests-99.96%** | **Common Stocks & Other Equity Interests-99.96%** |
| **Aerospace & Defense-8.07%** | **Aerospace & Defense-8.07%** | **Aerospace & Defense-8.07%** |
| ATI, Inc.<sup>(b)</sup> | 27934 | &nbsp;&nbsp; $3360460 |
| Carpenter Technology Corp. | 12512 | &nbsp;&nbsp; 3976689 |
|  |  | &nbsp;&nbsp; 7337149 |
| **Aluminum-7.61%** | **Aluminum-7.61%** | **Aluminum-7.61%** |
| Alcoa Corp. | 54130 | &nbsp;&nbsp; 3075125 |
| Century Aluminum Co.<sup>(b)(c)</sup> | 57533 | &nbsp;&nbsp; 2607971 |
| Kaiser Aluminum Corp. | 10058 | &nbsp;&nbsp; 1233312 |
|  |  | &nbsp;&nbsp; 6916408 |
| **Coal & Consumable Fuels-4.81%** | **Coal & Consumable Fuels-4.81%** | **Coal & Consumable Fuels-4.81%** |
| Uranium Energy Corp.<sup>(b)(c)</sup> | 253497 | &nbsp;&nbsp; 4370288 |
| **Commodity Chemicals-3.50%** | **Commodity Chemicals-3.50%** | **Commodity Chemicals-3.50%** |
| Cabot Corp. | 15148 | &nbsp;&nbsp; 1093534 |
| Hawkins, Inc. | 8346 | &nbsp;&nbsp; 1087067 |
| Westlake Corp.<sup>(c)</sup> | 12641 | &nbsp;&nbsp; 1002684 |
|  |  | &nbsp;&nbsp; 3183285 |
| **Copper-3.13%** | **Copper-3.13%** | **Copper-3.13%** |
| Freeport-McMoRan, Inc. | 47224 | &nbsp;&nbsp; 2844302 |
| **Diversified Chemicals-2.38%** | **Diversified Chemicals-2.38%** | **Diversified Chemicals-2.38%** |
| Chemours Co. (The)<sup>(c)</sup> | 77871 | &nbsp;&nbsp; 1167286 |
| Huntsman Corp. | 92350 | &nbsp;&nbsp; 999227 |
|  |  | &nbsp;&nbsp; 2166513 |
| **Diversified Metals & Mining-8.24%** | **Diversified Metals & Mining-8.24%** | **Diversified Metals & Mining-8.24%** |
| Idaho Strategic Resources, Inc.<sup>(b)(c)</sup> | 27719 | &nbsp;&nbsp; 999547 |
| Ivanhoe Electric, Inc.<sup>(b)(c)</sup> | 129028 | &nbsp;&nbsp; 2205089 |
| Materion Corp. | 8200 | &nbsp;&nbsp; 1133896 |
| MP Materials Corp.<sup>(b)(c)</sup> | 53608 | &nbsp;&nbsp; 3150542 |
|  |  | &nbsp;&nbsp; 7489074 |
| **Fertilizers & Agricultural Chemicals-4.70%** | **Fertilizers & Agricultural Chemicals-4.70%** | **Fertilizers & Agricultural Chemicals-4.70%** |
| Corteva, Inc. | 39985 | &nbsp;&nbsp; 2910908 |
| Scotts Miracle-Gro Co. (The) | 21197 | &nbsp;&nbsp; 1361271 |
|  |  | &nbsp;&nbsp; 4272179 |
| **Forest Products-1.52%** | **Forest Products-1.52%** | **Forest Products-1.52%** |
| Louisiana-Pacific Corp. | 16548 | &nbsp;&nbsp; 1385730 |
| **Gold-11.60%** | **Gold-11.60%** | **Gold-11.60%** |
| Coeur Mining, Inc.<sup>(b)</sup> | 141820 | &nbsp;&nbsp; 2898801 |
| Newmont Corp. | 36965 | &nbsp;&nbsp; 4153018 |
| Royal Gold, Inc. | 13262 | &nbsp;&nbsp; 3492017 |
|  |  | &nbsp;&nbsp; 10543836 |
| **Industrial Gases-2.12%** | **Industrial Gases-2.12%** | **Industrial Gases-2.12%** |
| Linde PLC | 4222 | &nbsp;&nbsp; 1929327 |
| **Metal, Glass & Plastic Containers-0.88%** | **Metal, Glass & Plastic Containers-0.88%** | **Metal, Glass & Plastic Containers-0.88%** |
| O-I Glass, Inc.<sup>(b)</sup> | 52083 | &nbsp;&nbsp; 795828 |
| **Paper & Plastic Packaging Products & Materials-3.91%** | **Paper & Plastic Packaging Products & Materials-3.91%** | **Paper & Plastic Packaging Products & Materials-3.91%** |
| Avery Dennison Corp. | 12060 | &nbsp;&nbsp; 2237251 |
| International Paper Co. | 32744 | &nbsp;&nbsp; 1320238 |
|  |  | &nbsp;&nbsp; 3557489 |
| **Paper Products-2.03%** | **Paper Products-2.03%** | **Paper Products-2.03%** |
| Magnera Corp.<sup>(b)(c)</sup> | 55058 | &nbsp;&nbsp; 719608 |
| Sylvamo Corp. | 22933 | &nbsp;&nbsp; 1122341 |
|  |  | &nbsp;&nbsp; 1841949 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Silver-4.93%** | **Silver-4.93%** | **Silver-4.93%** |
| Hecla Mining Co. | 198979 | &nbsp;&nbsp; $4481007 |
| **Specialty Chemicals-20.48%** | **Specialty Chemicals-20.48%** | **Specialty Chemicals-20.48%** |
| Albemarle Corp. | 20676 | &nbsp;&nbsp; 3527946 |
| Ashland, Inc. | 15727 | &nbsp;&nbsp; 961863 |
| Balchem Corp. | 4781 | &nbsp;&nbsp; 813583 |
| DuPont de Nemours, Inc. | 56849 | &nbsp;&nbsp; 2496808 |
| Ecolab, Inc. | 5627 | &nbsp;&nbsp; 1586758 |
| Element Solutions, Inc.<sup>(c)</sup> | 63094 | &nbsp;&nbsp; 1836035 |
| Ingevity Corp.<sup>(b)</sup> | 19000 | &nbsp;&nbsp; 1250010 |
| NewMarket Corp. | 2628 | &nbsp;&nbsp; 1762836 |
| Perimeter Solutions, Inc.<sup>(b)</sup> | 43682 | &nbsp;&nbsp; 1142284 |
| Quaker Chemical Corp. | 5301 | &nbsp;&nbsp; 814976 |
| RPM International, Inc. | 13277 | &nbsp;&nbsp; 1420108 |
| Sensient Technologies Corp. | 10654 | &nbsp;&nbsp; 1007016 |
|  |  | &nbsp;&nbsp; 18620223 |
| **Steel-10.05%** | **Steel-10.05%** | **Steel-10.05%** |
| Cleveland-Cliffs, Inc.<sup>(b)(c)</sup> | 134775 | &nbsp;&nbsp; 1854504 |
| Commercial Metals Co. | 20413 | &nbsp;&nbsp; 1569147 |
| Nucor Corp. | 8638 | &nbsp;&nbsp; 1535145 |
| Reliance, Inc. | 5013 | &nbsp;&nbsp; 1651784 |
| Steel Dynamics, Inc. | 14035 | &nbsp;&nbsp; 2520265 |
|  |  | &nbsp;&nbsp; 9130845 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $64,863,444) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $64,863,444) | &nbsp;&nbsp; 90865432 |
| **Money Market Funds-0.20%** | **Money Market Funds-0.20%** | **Money Market Funds-0.20%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(d)(e)</sup> <br>(Cost $186,338)<br>| 186338 | &nbsp;&nbsp; 186338 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.16% <br>(Cost $65,049,782) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.16% <br>(Cost $65,049,782) | &nbsp;&nbsp; 91051770 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-11.74%** | **Money Market Funds-11.74%** | **Money Market Funds-11.74%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(d)(e)(f)</sup><br>| 2479390 | &nbsp;&nbsp; 2479390 |
| Invesco Private Prime Fund, 3.80%<sup>(d)(e)(f)</sup> | 8190426 | &nbsp;&nbsp; 8192883 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $10,672,273) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $10,672,273) | &nbsp;&nbsp; 10672273 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-111.90% <br>(Cost $75,722,055) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-111.90% <br>(Cost $75,722,055) | &nbsp;&nbsp; 101724043 |
| OTHER ASSETS LESS LIABILITIES-(11.90)% | OTHER ASSETS LESS LIABILITIES-(11.90)% | &nbsp;&nbsp; (10820806)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $90903237 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ)—(continued)**

January 31, 2026

*(Unaudited)*

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $130424 | &nbsp;&nbsp;&nbsp; $848522 | &nbsp;&nbsp;&nbsp; $(792608)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $186338 | &nbsp;&nbsp;&nbsp; $4542 |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; 2023918 | &nbsp;&nbsp;&nbsp; 31431915 | &nbsp;&nbsp;&nbsp; (30976443)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 2479390 | &nbsp;&nbsp;&nbsp; 85,519<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 5262219 | &nbsp;&nbsp;&nbsp; 73970207 | &nbsp;&nbsp;&nbsp; (71040434)<br>| &nbsp;&nbsp;&nbsp; 106 | &nbsp;&nbsp;&nbsp; 785 | &nbsp;&nbsp;&nbsp; 8192883 | &nbsp;&nbsp;&nbsp; 231,297<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $7416561 | &nbsp;&nbsp;&nbsp; $106250644 | &nbsp;&nbsp;&nbsp; $(102809485)<br>| &nbsp;&nbsp;&nbsp; $106 | &nbsp;&nbsp;&nbsp; $785 | &nbsp;&nbsp;&nbsp; $10858611 | &nbsp;&nbsp;&nbsp; $321358 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Consumer Cyclicals Momentum ETF (PEZ)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.88%** | **Common Stocks & Other Equity Interests-99.88%** | **Common Stocks & Other Equity Interests-99.88%** |
| **Apparel Retail-16.50%** | **Apparel Retail-16.50%** | **Apparel Retail-16.50%** |
| Abercrombie & Fitch Co., Class A<sup>(b)</sup> | 4887 | &nbsp;&nbsp; $477118 |
| American Eagle Outfitters, Inc. | 28537 | &nbsp;&nbsp; 665197 |
| Boot Barn Holdings, Inc.<sup>(b)</sup> | 2308 | &nbsp;&nbsp; 411932 |
| Buckle, Inc. (The) | 7026 | &nbsp;&nbsp; 332330 |
| RealReal, Inc. (The)<sup>(b)(c)</sup> | 34297 | &nbsp;&nbsp; 503137 |
| Revolve Group, Inc.<sup>(b)</sup> | 9999 | &nbsp;&nbsp; 276472 |
| Urban Outfitters, Inc.<sup>(b)</sup> | 7811 | &nbsp;&nbsp; 553409 |
| Victoria's Secret & Co.<sup>(b)(c)</sup> | 15666 | &nbsp;&nbsp; 853954 |
|  |  | &nbsp;&nbsp; 4073549 |
| **Apparel, Accessories & Luxury Goods-9.42%** | **Apparel, Accessories & Luxury Goods-9.42%** | **Apparel, Accessories & Luxury Goods-9.42%** |
| Figs, Inc., Class A<sup>(b)</sup> | 27996 | &nbsp;&nbsp; 302637 |
| Ralph Lauren Corp. | 2767 | &nbsp;&nbsp; 977885 |
| Tapestry, Inc. | 8248 | &nbsp;&nbsp; 1046754 |
|  |  | &nbsp;&nbsp; 2327276 |
| **Automobile Manufacturers-7.15%** | **Automobile Manufacturers-7.15%** | **Automobile Manufacturers-7.15%** |
| General Motors Co. | 8124 | &nbsp;&nbsp; 682416 |
| Rivian Automotive, Inc., Class A<sup>(b)</sup> | 28985 | &nbsp;&nbsp; 427529 |
| Tesla, Inc.<sup>(b)</sup> | 1524 | &nbsp;&nbsp; 655945 |
|  |  | &nbsp;&nbsp; 1765890 |
| **Automotive Parts & Equipment-5.48%** | **Automotive Parts & Equipment-5.48%** | **Automotive Parts & Equipment-5.48%** |
| Dana, Inc. | 21374 | &nbsp;&nbsp; 617709 |
| Garrett Motion, Inc. (Switzerland) | 24486 | &nbsp;&nbsp; 441727 |
| XPEL, Inc.<sup>(b)(c)(d)</sup> | 5680 | &nbsp;&nbsp; 292577 |
|  |  | &nbsp;&nbsp; 1352013 |
| **Automotive Retail-3.89%** | **Automotive Retail-3.89%** | **Automotive Retail-3.89%** |
| Carvana Co.<sup>(b)</sup> | 2397 | &nbsp;&nbsp; 961461 |
| **Broadline Retail-5.60%** | **Broadline Retail-5.60%** | **Broadline Retail-5.60%** |
| Amazon.com, Inc.<sup>(b)</sup> | 4047 | &nbsp;&nbsp; 968447 |
| Dillard's, Inc., Class A<sup>(c)</sup> | 684 | &nbsp;&nbsp; 415571 |
|  |  | &nbsp;&nbsp; 1384018 |
| **Cable & Satellite-4.38%** | **Cable & Satellite-4.38%** | **Cable & Satellite-4.38%** |
| EchoStar Corp., Class A<sup>(b)(c)</sup> | 9545 | &nbsp;&nbsp; 1080685 |
| **Casinos & Gaming-1.86%** | **Casinos & Gaming-1.86%** | **Casinos & Gaming-1.86%** |
| Las Vegas Sands Corp. | 8691 | &nbsp;&nbsp; 458276 |
| **Consumer Staples Merchandise Retail-2.73%** | **Consumer Staples Merchandise Retail-2.73%** | **Consumer Staples Merchandise Retail-2.73%** |
| Dollar General Corp. | 4691 | &nbsp;&nbsp; 672830 |
| **Distributors-1.44%** | **Distributors-1.44%** | **Distributors-1.44%** |
| GigaCloud Technology, Inc., Class A<sup>(b)(c)</sup> | 8895 | &nbsp;&nbsp; 355177 |
| **Diversified Support Services-1.17%** | **Diversified Support Services-1.17%** | **Diversified Support Services-1.17%** |
| OPENLANE, Inc.<sup>(b)</sup> | 9643 | &nbsp;&nbsp; 289676 |
| **Health Care Distributors-7.90%** | **Health Care Distributors-7.90%** | **Health Care Distributors-7.90%** |
| Cardinal Health, Inc. | 4356 | &nbsp;&nbsp; 936017 |
| McKesson Corp. | 1220 | &nbsp;&nbsp; 1014076 |
|  |  | &nbsp;&nbsp; 1950093 |
| **Home Furnishings-3.77%** | **Home Furnishings-3.77%** | **Home Furnishings-3.77%** |
| Somnigroup International, Inc. | 10586 | &nbsp;&nbsp; 929980 |
| **Homefurnishing Retail-6.98%** | **Homefurnishing Retail-6.98%** | **Homefurnishing Retail-6.98%** |
| Wayfair, Inc., Class A<sup>(b)(c)</sup> | 9298 | &nbsp;&nbsp; 962250 |
| Williams-Sonoma, Inc. | 3722 | &nbsp;&nbsp; 761707 |
|  |  | &nbsp;&nbsp; 1723957 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Hotels, Resorts & Cruise Lines-5.38%** | **Hotels, Resorts & Cruise Lines-5.38%** | **Hotels, Resorts & Cruise Lines-5.38%** |
| Expedia Group, Inc. | 2308 | &nbsp;&nbsp; $611251 |
| Hilton Worldwide Holdings, Inc. | 2406 | &nbsp;&nbsp; 718215 |
|  |  | &nbsp;&nbsp; 1329466 |
| **Leisure Facilities-1.93%** | **Leisure Facilities-1.93%** | **Leisure Facilities-1.93%** |
| Planet Fitness, Inc., Class A<sup>(b)</sup> | 5242 | &nbsp;&nbsp; 477232 |
| **Leisure Products-1.92%** | **Leisure Products-1.92%** | **Leisure Products-1.92%** |
| Callaway Golf Co.<sup>(b)(c)</sup> | 33117 | &nbsp;&nbsp; 475229 |
| **Movies & Entertainment-2.16%** | **Movies & Entertainment-2.16%** | **Movies & Entertainment-2.16%** |
| Sphere Entertainment Co.<sup>(b)</sup> | 5594 | &nbsp;&nbsp; 534283 |
| **Other Specialty Retail-5.10%** | **Other Specialty Retail-5.10%** | **Other Specialty Retail-5.10%** |
| Five Below, Inc.<sup>(b)</sup> | 4140 | &nbsp;&nbsp; 793390 |
| National Vision Holdings, Inc.<sup>(b)(c)</sup> | 17703 | &nbsp;&nbsp; 466474 |
|  |  | &nbsp;&nbsp; 1259864 |
| **Passenger Airlines-3.93%** | **Passenger Airlines-3.93%** | **Passenger Airlines-3.93%** |
| Allegiant Travel Co.<sup>(b)</sup> | 3479 | &nbsp;&nbsp; 308344 |
| United Airlines Holdings, Inc.<sup>(b)</sup> | 6468 | &nbsp;&nbsp; 661805 |
|  |  | &nbsp;&nbsp; 970149 |
| **Restaurants-1.19%** | **Restaurants-1.19%** | **Restaurants-1.19%** |
| Dine Brands Global, Inc.<sup>(c)</sup> | 8554 | &nbsp;&nbsp; 294172 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $23,036,206) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $23,036,206) | &nbsp;&nbsp; 24665276 |
| **Money Market Funds-0.58%** | **Money Market Funds-0.58%** | **Money Market Funds-0.58%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(e)(f)</sup> <br>(Cost $144,741)<br>| 144741 | &nbsp;&nbsp; 144741 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.46% <br>(Cost $23,180,947) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.46% <br>(Cost $23,180,947) | &nbsp;&nbsp; 24810017 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-11.47%** | **Money Market Funds-11.47%** | **Money Market Funds-11.47%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(e)(f)(g)</sup><br>| 783036 | &nbsp;&nbsp; 783036 |
| Invesco Private Prime Fund, 3.80%<sup>(e)(f)(g)</sup> | 2048254 | &nbsp;&nbsp; 2048868 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $2,831,904) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $2,831,904) | &nbsp;&nbsp; 2831904 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-111.93% <br>(Cost $26,012,851) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-111.93% <br>(Cost $26,012,851) | &nbsp;&nbsp; 27641921 |
| OTHER ASSETS LESS LIABILITIES-(11.93)% | OTHER ASSETS LESS LIABILITIES-(11.93)% | &nbsp;&nbsp; (2946409)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $24695512 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Consumer Cyclicals Momentum ETF (PEZ)—(continued)**

January 31, 2026

*(Unaudited)*

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Security purchased or received in a transaction exempt from registration under the Securities Act of 1933, as amended (the "1933 Act"). The security may be <br> resold pursuant to an exemption from registration under the 1933 Act, typically to qualified institutional buyers. The value of this security at January 31, 2026 <br> represented 1.18% of the Fund's Net Assets.<br>|
| <sup>(e)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain** <br>**(Loss)**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, Institutional <br> Class<br>| &nbsp;&nbsp;&nbsp; $136511 | &nbsp;&nbsp;&nbsp; $391742 | &nbsp;&nbsp;&nbsp; $(383512)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $144741 | &nbsp;&nbsp;&nbsp; $3737 |
| **Investments Purchased with** <br> **Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private Government <br> Fund<br>| &nbsp;&nbsp;&nbsp; 4487712 | &nbsp;&nbsp;&nbsp; 20776458 | &nbsp;&nbsp;&nbsp; (24481134)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 783036 | &nbsp;&nbsp;&nbsp; 47,052<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 7998580 | &nbsp;&nbsp;&nbsp; 42513010 | &nbsp;&nbsp;&nbsp; (48462704)<br>| &nbsp;&nbsp;&nbsp; 232 | &nbsp;&nbsp;&nbsp; (250)<br>| &nbsp;&nbsp;&nbsp; 2048868 | &nbsp;&nbsp;&nbsp; 130,236<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $12622803 | &nbsp;&nbsp;&nbsp; $63681210 | &nbsp;&nbsp;&nbsp; $(73327350)<br>| &nbsp;&nbsp;&nbsp; $232 | &nbsp;&nbsp;&nbsp; $(250)<br>| &nbsp;&nbsp;&nbsp; $2976645 | &nbsp;&nbsp;&nbsp; $181025 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(f)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(g)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Consumer Staples Momentum ETF (PSL)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.97%** | **Common Stocks & Other Equity Interests-99.97%** | **Common Stocks & Other Equity Interests-99.97%** |
| **Agricultural Products & Services-8.05%** | **Agricultural Products & Services-8.05%** | **Agricultural Products & Services-8.05%** |
| Archer-Daniels-Midland Co. | 40728 | &nbsp;&nbsp; $2741402 |
| Bunge Global S.A. | 16909 | &nbsp;&nbsp; 1925597 |
| Darling Ingredients, Inc.<sup>(b)</sup> | 30920 | &nbsp;&nbsp; 1411807 |
| Ingredion, Inc. | 10183 | &nbsp;&nbsp; 1202612 |
|  |  | &nbsp;&nbsp; 7281418 |
| **Consumer Finance-1.66%** | **Consumer Finance-1.66%** | **Consumer Finance-1.66%** |
| EZCORP, Inc., Class A<sup>(b)(c)</sup> | 70105 | &nbsp;&nbsp; 1503752 |
| **Consumer Staples Merchandise Retail-7.11%** | **Consumer Staples Merchandise Retail-7.11%** | **Consumer Staples Merchandise Retail-7.11%** |
| BJ's Wholesale Club Holdings, Inc.<sup>(b)</sup> | 29626 | &nbsp;&nbsp; 2738628 |
| Costco Wholesale Corp. | 3922 | &nbsp;&nbsp; 3687661 |
|  |  | &nbsp;&nbsp; 6426289 |
| **Distillers & Vintners-1.13%** | **Distillers & Vintners-1.13%** | **Distillers & Vintners-1.13%** |
| Brown-Forman Corp., Class B | 37310 | &nbsp;&nbsp; 1021175 |
| **Education Services-8.40%** | **Education Services-8.40%** | **Education Services-8.40%** |
| Adtalem Global Education, Inc.<sup>(b)</sup> | 18838 | &nbsp;&nbsp; 1950675 |
| Grand Canyon Education, Inc.<sup>(b)</sup> | 8055 | &nbsp;&nbsp; 1400281 |
| Laureate Education, Inc., Class A<sup>(b)</sup> | 59823 | &nbsp;&nbsp; 2051929 |
| Perdoceo Education Corp. | 39238 | &nbsp;&nbsp; 1256793 |
| Universal Technical Institute, Inc.<sup>(b)(c)</sup> | 33483 | &nbsp;&nbsp; 931832 |
|  |  | &nbsp;&nbsp; 7591510 |
| **Food Distributors-9.79%** | **Food Distributors-9.79%** | **Food Distributors-9.79%** |
| Andersons, Inc. (The) | 17959 | &nbsp;&nbsp; 1113278 |
| Chefs' Warehouse, Inc. (The)<sup>(b)</sup> | 20404 | &nbsp;&nbsp; 1283412 |
| Performance Food Group Co.<sup>(b)</sup> | 20025 | &nbsp;&nbsp; 1911386 |
| United Natural Foods, Inc.<sup>(b)</sup> | 35263 | &nbsp;&nbsp; 1312842 |
| US Foods Holding Corp.<sup>(b)</sup> | 38702 | &nbsp;&nbsp; 3236261 |
|  |  | &nbsp;&nbsp; 8857179 |
| **Food Retail-7.50%** | **Food Retail-7.50%** | **Food Retail-7.50%** |
| Casey's General Stores, Inc. | 6538 | &nbsp;&nbsp; 3965297 |
| Kroger Co. (The) | 44748 | &nbsp;&nbsp; 2812412 |
|  |  | &nbsp;&nbsp; 6777709 |
| **Household Appliances-0.79%** | **Household Appliances-0.79%** | **Household Appliances-0.79%** |
| Helen of Troy Ltd.<sup>(b)(c)</sup> | 43102 | &nbsp;&nbsp; 713769 |
| **Household Products-10.05%** | **Household Products-10.05%** | **Household Products-10.05%** |
| Church & Dwight Co., Inc. | 41133 | &nbsp;&nbsp; 3959051 |
| Energizer Holdings, Inc.<sup>(c)</sup> | 44725 | &nbsp;&nbsp; 976347 |
| Procter & Gamble Co. (The) | 21082 | &nbsp;&nbsp; 3199615 |
| Spectrum Brands Holdings, Inc.<sup>(c)</sup> | 14934 | &nbsp;&nbsp; 951445 |
|  |  | &nbsp;&nbsp; 9086458 |
| **Packaged Foods & Meats-12.64%** | **Packaged Foods & Meats-12.64%** | **Packaged Foods & Meats-12.64%** |
| Cal-Maine Foods, Inc. | 18019 | &nbsp;&nbsp; 1505127 |
| Freshpet, Inc.<sup>(b)(c)</sup> | 17552 | &nbsp;&nbsp; 1223375 |
| Hershey Co. (The) | 8047 | &nbsp;&nbsp; 1567153 |
| J&J Snack Foods Corp. | 9519 | &nbsp;&nbsp; 904305 |
| Marzetti Co. (The) | 5386 | &nbsp;&nbsp; 924076 |
| Post Holdings, Inc.<sup>(b)(c)</sup> | 15633 | &nbsp;&nbsp; 1599412 |
| Seaboard Corp. | 222 | &nbsp;&nbsp; 1128266 |
| Tyson Foods, Inc., Class A | 25482 | &nbsp;&nbsp; 1664739 |
| Vital Farms, Inc.<sup>(b)(c)</sup> | 32207 | &nbsp;&nbsp; 916289 |
|  |  | &nbsp;&nbsp; 11432742 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Personal Care Products-6.49%** | **Personal Care Products-6.49%** | **Personal Care Products-6.49%** |
| e.l.f. Beauty, Inc.<sup>(b)(c)</sup> | 17401 | &nbsp;&nbsp; $1478911 |
| Estee Lauder Cos., Inc. (The), Class A | 24342 | &nbsp;&nbsp; 2806146 |
| Herbalife Ltd.<sup>(b)</sup> | 91826 | &nbsp;&nbsp; 1583080 |
|  |  | &nbsp;&nbsp; 5868137 |
| **Soft Drinks & Non-alcoholic Beverages-14.19%** | **Soft Drinks & Non-alcoholic Beverages-14.19%** | **Soft Drinks & Non-alcoholic Beverages-14.19%** |
| Celsius Holdings, Inc.<sup>(b)</sup> | 45074 | &nbsp;&nbsp; 2365484 |
| Coca-Cola Co. (The) | 32311 | &nbsp;&nbsp; 2417186 |
| Coca-Cola Consolidated, Inc. | 12597 | &nbsp;&nbsp; 1915500 |
| Monster Beverage Corp.<sup>(b)</sup> | 39657 | &nbsp;&nbsp; 3202699 |
| PepsiCo, Inc. | 9659 | &nbsp;&nbsp; 1483912 |
| Primo Brands Corp.<sup>(c)</sup> | 76165 | &nbsp;&nbsp; 1442565 |
|  |  | &nbsp;&nbsp; 12827346 |
| **Specialized Consumer Services-2.46%** | **Specialized Consumer Services-2.46%** | **Specialized Consumer Services-2.46%** |
| Service Corp. International | 27708 | &nbsp;&nbsp; 2228554 |
| **Tobacco-9.71%** | **Tobacco-9.71%** | **Tobacco-9.71%** |
| Altria Group, Inc. | 46617 | &nbsp;&nbsp; 2889788 |
| Philip Morris International, Inc. | 20702 | &nbsp;&nbsp; 3714767 |
| Turning Point Brands, Inc. | 17925 | &nbsp;&nbsp; 2171614 |
|  |  | &nbsp;&nbsp; 8776169 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $73,872,100) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $73,872,100) | &nbsp;&nbsp; 90392207 |
| **Money Market Funds-0.17%** | **Money Market Funds-0.17%** | **Money Market Funds-0.17%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(d)(e)</sup> <br>(Cost $150,302)<br>| 150302 | &nbsp;&nbsp; 150302 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.14% <br>(Cost $74,022,402) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.14% <br>(Cost $74,022,402) | &nbsp;&nbsp; 90542509 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-9.47%** | **Money Market Funds-9.47%** | **Money Market Funds-9.47%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(d)(e)(f)</sup><br>| 2382838 | &nbsp;&nbsp; 2382838 |
| Invesco Private Prime Fund, 3.80%<sup>(d)(e)(f)</sup> | 6181667 | &nbsp;&nbsp; 6183522 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $8,566,359) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $8,566,359) | &nbsp;&nbsp; 8566360 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-109.61% <br>(Cost $82,588,761) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-109.61% <br>(Cost $82,588,761) | &nbsp;&nbsp; 99108869 |
| OTHER ASSETS LESS LIABILITIES-(9.61)% | OTHER ASSETS LESS LIABILITIES-(9.61)% | &nbsp;&nbsp; (8692231)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $90416638 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Consumer Staples Momentum ETF (PSL)—(continued)**

January 31, 2026

*(Unaudited)*

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $208916 | &nbsp;&nbsp;&nbsp; $1419498 | &nbsp;&nbsp;&nbsp; $(1478112)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $150302 | &nbsp;&nbsp;&nbsp; $5081 |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; 4827252 | &nbsp;&nbsp;&nbsp; 33674067 | &nbsp;&nbsp;&nbsp; (36118481)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 2382838 | &nbsp;&nbsp;&nbsp; 89,860<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 12565489 | &nbsp;&nbsp;&nbsp; 72877691 | &nbsp;&nbsp;&nbsp; (79260422)<br>| &nbsp;&nbsp;&nbsp; 296 | &nbsp;&nbsp;&nbsp; 468 | &nbsp;&nbsp;&nbsp; 6183522 | &nbsp;&nbsp;&nbsp; 242,393<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $17601657 | &nbsp;&nbsp;&nbsp; $107971256 | &nbsp;&nbsp;&nbsp; $(116857015)<br>| &nbsp;&nbsp;&nbsp; $296 | &nbsp;&nbsp;&nbsp; $468 | &nbsp;&nbsp;&nbsp; $8716662 | &nbsp;&nbsp;&nbsp; $337334 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Energy Momentum ETF (PXI)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.95%** | **Common Stocks & Other Equity Interests-99.95%** | **Common Stocks & Other Equity Interests-99.95%** |
| **Coal & Consumable Fuels-6.79%** | **Coal & Consumable Fuels-6.79%** | **Coal & Consumable Fuels-6.79%** |
| Centrus Energy Corp., Class A<sup>(b)(c)</sup> | 6238 | &nbsp;&nbsp; $1735911 |
| Peabody Energy Corp. | 32486 | &nbsp;&nbsp; 1145456 |
|  |  | &nbsp;&nbsp; 2881367 |
| **Integrated Oil & Gas-5.79%** | **Integrated Oil & Gas-5.79%** | **Integrated Oil & Gas-5.79%** |
| Chevron Corp. | 5777 | &nbsp;&nbsp; 1021951 |
| Exxon Mobil Corp. | 10145 | &nbsp;&nbsp; 1434503 |
|  |  | &nbsp;&nbsp; 2456454 |
| **Oil & Gas Drilling-2.33%** | **Oil & Gas Drilling-2.33%** | **Oil & Gas Drilling-2.33%** |
| Helmerich & Payne, Inc. | 16674 | &nbsp;&nbsp; 564915 |
| Nabors Industries Ltd.<sup>(b)(c)</sup> | 6344 | &nbsp;&nbsp; 424033 |
|  |  | &nbsp;&nbsp; 988948 |
| **Oil & Gas Equipment & Services-17.39%** | **Oil & Gas Equipment & Services-17.39%** | **Oil & Gas Equipment & Services-17.39%** |
| Archrock, Inc. | 27026 | &nbsp;&nbsp; 799699 |
| Baker Hughes Co., Class A | 30794 | &nbsp;&nbsp; 1725696 |
| Expro Group Holdings N.V.<sup>(b)</sup> | 23156 | &nbsp;&nbsp; 370728 |
| Kodiak Gas Services, Inc. | 15123 | &nbsp;&nbsp; 635317 |
| Liberty Energy, Inc., Class A | 37713 | &nbsp;&nbsp; 929625 |
| ProPetro Holding Corp.<sup>(b)</sup> | 36307 | &nbsp;&nbsp; 417167 |
| TETRA Technologies, Inc.<sup>(b)</sup> | 49819 | &nbsp;&nbsp; 567937 |
| Tidewater, Inc.<sup>(b)</sup> | 12150 | &nbsp;&nbsp; 759254 |
| Weatherford International PLC | 12455 | &nbsp;&nbsp; 1171766 |
|  |  | &nbsp;&nbsp; 7377189 |
| **Oil & Gas Exploration & Production-27.60%** | **Oil & Gas Exploration & Production-27.60%** | **Oil & Gas Exploration & Production-27.60%** |
| Antero Resources Corp.<sup>(b)</sup> | 19461 | &nbsp;&nbsp; 707797 |
| APA Corp. | 28150 | &nbsp;&nbsp; 743441 |
| BKV Corp. (Thailand)<sup>(b)(c)</sup> | 15711 | &nbsp;&nbsp; 467402 |
| CNX Resources Corp.<sup>(b)</sup> | 22150 | &nbsp;&nbsp; 859420 |
| Comstock Resources, Inc.<sup>(b)(c)</sup> | 41896 | &nbsp;&nbsp; 1020168 |
| ConocoPhillips | 10004 | &nbsp;&nbsp; 1042717 |
| Devon Energy Corp. | 23326 | &nbsp;&nbsp; 937938 |
| Diamondback Energy, Inc. | 7099 | &nbsp;&nbsp; 1163881 |
| Expand Energy Corp. | 6219 | &nbsp;&nbsp; 699078 |
| Gulfport Energy Corp.<sup>(b)</sup> | 4677 | &nbsp;&nbsp; 954903 |
| Magnolia Oil & Gas Corp., Class A | 22357 | &nbsp;&nbsp; 570327 |
| Permian Resources Corp. | 63189 | &nbsp;&nbsp; 1019239 |
| Sable Offshore Corp.<sup>(b)(c)</sup> | 91167 | &nbsp;&nbsp; 882496 |
| Viper Energy, Inc., Class A | 15050 | &nbsp;&nbsp; 637217 |
|  |  | &nbsp;&nbsp; 11706024 |
| **Oil & Gas Refining & Marketing-18.65%** | **Oil & Gas Refining & Marketing-18.65%** | **Oil & Gas Refining & Marketing-18.65%** |
| Calumet, Inc.<sup>(b)(c)</sup> | 21497 | &nbsp;&nbsp; 481748 |
| CVR Energy, Inc.<sup>(b)</sup> | 16118 | &nbsp;&nbsp; 366523 |
| Delek US Holdings, Inc.<sup>(c)</sup> | 18303 | &nbsp;&nbsp; 540121 |
| Green Plains, Inc.<sup>(b)</sup> | 40698 | &nbsp;&nbsp; 466399 |
| HF Sinclair Corp. | 9247 | &nbsp;&nbsp; 480752 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Oil & Gas Refining & Marketing-(continued)** | **Oil & Gas Refining & Marketing-(continued)** | **Oil & Gas Refining & Marketing-(continued)** |
| Marathon Petroleum Corp. | 12544 | &nbsp;&nbsp; $2210127 |
| Par Pacific Holdings, Inc.<sup>(b)</sup> | 16809 | &nbsp;&nbsp; 634372 |
| PBF Energy, Inc., Class A | 17046 | &nbsp;&nbsp; 570359 |
| Phillips 66 | 5173 | &nbsp;&nbsp; 742636 |
| Valero Energy Corp. | 7799 | &nbsp;&nbsp; 1414973 |
|  |  | &nbsp;&nbsp; 7908010 |
| **Oil & Gas Storage & Transportation-17.64%** | **Oil & Gas Storage & Transportation-17.64%** | **Oil & Gas Storage & Transportation-17.64%** |
| Antero Midstream Corp. | 42272 | &nbsp;&nbsp; 795559 |
| DT Midstream, Inc. | 7367 | &nbsp;&nbsp; 928389 |
| Kinder Morgan, Inc. | 48360 | &nbsp;&nbsp; 1474497 |
| Targa Resources Corp. | 12371 | &nbsp;&nbsp; 2486324 |
| Williams Cos., Inc. (The) | 26712 | &nbsp;&nbsp; 1796649 |
|  |  | &nbsp;&nbsp; 7481418 |
| **Steel-3.76%** | **Steel-3.76%** | **Steel-3.76%** |
| Alpha Metallurgical Resources, Inc.<sup>(b)</sup> | 3701 | &nbsp;&nbsp; 776470 |
| Warrior Met Coal, Inc. | 9167 | &nbsp;&nbsp; 818613 |
|  |  | &nbsp;&nbsp; 1595083 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $33,601,450) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $33,601,450) | &nbsp;&nbsp; 42394493 |
| **Money Market Funds-0.32%** | **Money Market Funds-0.32%** | **Money Market Funds-0.32%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(d)(e)</sup> <br>(Cost $136,009)<br>| 136009 | &nbsp;&nbsp; 136009 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.27% <br>(Cost $33,737,459) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.27% <br>(Cost $33,737,459) | &nbsp;&nbsp; 42530502 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-13.57%** | **Money Market Funds-13.57%** | **Money Market Funds-13.57%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(d)(e)(f)</sup><br>| 1600722 | &nbsp;&nbsp; 1600722 |
| Invesco Private Prime Fund, 3.80%<sup>(d)(e)(f)</sup> | 4154298 | &nbsp;&nbsp; 4155544 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $5,756,266) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $5,756,266) | &nbsp;&nbsp; 5756266 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-113.84% <br>(Cost $39,493,725) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-113.84% <br>(Cost $39,493,725) | &nbsp;&nbsp; 48286768 |
| OTHER ASSETS LESS LIABILITIES-(13.84)% | OTHER ASSETS LESS LIABILITIES-(13.84)% | &nbsp;&nbsp; (5869501)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $42417267 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Energy Momentum ETF (PXI)—(continued)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, Institutional <br> Class<br>| &nbsp;&nbsp;&nbsp; $156950 | &nbsp;&nbsp;&nbsp; $1316581 | &nbsp;&nbsp;&nbsp; $(1337522)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $136009 | &nbsp;&nbsp;&nbsp; $4079 |
| **Investments Purchased with** <br> **Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private Government <br> Fund<br>| &nbsp;&nbsp;&nbsp; 2734661 | &nbsp;&nbsp;&nbsp; 26749308 | &nbsp;&nbsp;&nbsp; (27883247)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 1600722 | &nbsp;&nbsp;&nbsp; 66,375<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 7109338 | &nbsp;&nbsp;&nbsp; 55359352 | &nbsp;&nbsp;&nbsp; (58313367)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 221 | &nbsp;&nbsp;&nbsp; 4155544 | &nbsp;&nbsp;&nbsp; 180,409<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $10000949 | &nbsp;&nbsp;&nbsp; $83425241 | &nbsp;&nbsp;&nbsp; $(87534136)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $221 | &nbsp;&nbsp;&nbsp; $5892275 | &nbsp;&nbsp;&nbsp; $250863 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Financial Momentum ETF (PFI)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.99%** | **Common Stocks & Other Equity Interests-99.99%** | **Common Stocks & Other Equity Interests-99.99%** |
| **Asset Management & Custody Banks-10.84%** | **Asset Management & Custody Banks-10.84%** | **Asset Management & Custody Banks-10.84%** |
| Bank of New York Mellon Corp. (The) | 12650 | &nbsp;&nbsp; $1516988 |
| BlackRock, Inc. | 1322 | &nbsp;&nbsp; 1479238 |
| DigitalBridge Group, Inc.<sup>(b)</sup> | 55931 | &nbsp;&nbsp; 860778 |
| Invesco Ltd.<sup>(c)</sup> | 53792 | &nbsp;&nbsp; 1467984 |
| TPG, Inc. | 12446 | &nbsp;&nbsp; 733194 |
|  |  | &nbsp;&nbsp; 6058182 |
| **Consumer Finance-14.73%** | **Consumer Finance-14.73%** | **Consumer Finance-14.73%** |
| American Express Co. | 5972 | &nbsp;&nbsp; 2103159 |
| Capital One Financial Corp. | 6984 | &nbsp;&nbsp; 1529007 |
| Enova International, Inc.<sup>(d)</sup> | 8019 | &nbsp;&nbsp; 1324498 |
| LendingClub Corp.<sup>(d)</sup> | 51793 | &nbsp;&nbsp; 875820 |
| OneMain Holdings, Inc. | 16321 | &nbsp;&nbsp; 1069679 |
| Synchrony Financial | 18267 | &nbsp;&nbsp; 1326732 |
|  |  | &nbsp;&nbsp; 8228895 |
| **Diversified Banks-10.51%** | **Diversified Banks-10.51%** | **Diversified Banks-10.51%** |
| Citigroup, Inc. | 13354 | &nbsp;&nbsp; 1545191 |
| JPMorgan Chase & Co. | 9084 | &nbsp;&nbsp; 2778705 |
| Wells Fargo & Co. | 17071 | &nbsp;&nbsp; 1544755 |
|  |  | &nbsp;&nbsp; 5868651 |
| **Financial Exchanges & Data-6.44%** | **Financial Exchanges & Data-6.44%** | **Financial Exchanges & Data-6.44%** |
| Cboe Global Markets, Inc. | 5339 | &nbsp;&nbsp; 1415155 |
| Nasdaq, Inc. | 22529 | &nbsp;&nbsp; 2182835 |
|  |  | &nbsp;&nbsp; 3597990 |
| **Health Care REITs-7.61%** | **Health Care REITs-7.61%** | **Health Care REITs-7.61%** |
| American Healthcare REIT, Inc. | 24117 | &nbsp;&nbsp; 1131328 |
| Ventas, Inc. | 19428 | &nbsp;&nbsp; 1508973 |
| Welltower, Inc. | 8539 | &nbsp;&nbsp; 1608406 |
|  |  | &nbsp;&nbsp; 4248707 |
| **Investment Banking & Brokerage-19.36%** | **Investment Banking & Brokerage-19.36%** | **Investment Banking & Brokerage-19.36%** |
| Goldman Sachs Group, Inc. (The) | 2082 | &nbsp;&nbsp; 1947524 |
| Interactive Brokers Group, Inc., Class A | 34553 | &nbsp;&nbsp; 2587329 |
| Morgan Stanley | 11363 | &nbsp;&nbsp; 2077156 |
| Piper Sandler Cos. | 3486 | &nbsp;&nbsp; 1207376 |
| Raymond James Financial, Inc. | 12733 | &nbsp;&nbsp; 2111895 |
| Stifel Financial Corp. | 7160 | &nbsp;&nbsp; 882828 |
|  |  | &nbsp;&nbsp; 10814108 |
| **Other Specialized REITs-1.61%** | **Other Specialized REITs-1.61%** | **Other Specialized REITs-1.61%** |
| Outfront Media, Inc. | 36951 | &nbsp;&nbsp; 898648 |
| **Property & Casualty Insurance-12.25%** | **Property & Casualty Insurance-12.25%** | **Property & Casualty Insurance-12.25%** |
| AXIS Capital Holdings Ltd. | 7843 | &nbsp;&nbsp; 809241 |
| HCI Group, Inc. | 6635 | &nbsp;&nbsp; 1052775 |
| Heritage Insurance Holdings, Inc.<sup>(b)(d)</sup> | 24615 | &nbsp;&nbsp; 641713 |
| Lemonade, Inc.<sup>(b)(d)</sup> | 33277 | &nbsp;&nbsp; 2886114 |
| Mercury General Corp. | 6415 | &nbsp;&nbsp; 561890 |
| Old Republic International Corp. | 22729 | &nbsp;&nbsp; 890295 |
|  |  | &nbsp;&nbsp; 6842028 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Real Estate Services-4.44%** | **Real Estate Services-4.44%** | **Real Estate Services-4.44%** |
| CBRE Group, Inc., Class A<sup>(d)</sup> | 9706 | &nbsp;&nbsp; $1653223 |
| Jones Lang LaSalle, Inc.<sup>(d)</sup> | 2308 | &nbsp;&nbsp; 826056 |
|  |  | &nbsp;&nbsp; 2479279 |
| **Regional Banks-6.71%** | **Regional Banks-6.71%** | **Regional Banks-6.71%** |
| Ameris Bancorp | 9852 | &nbsp;&nbsp; 794269 |
| Citizens Financial Group, Inc. | 22650 | &nbsp;&nbsp; 1426497 |
| Coastal Financial Corp.<sup>(b)(d)</sup> | 5449 | &nbsp;&nbsp; 521905 |
| Popular, Inc. | 7540 | &nbsp;&nbsp; 1006816 |
|  |  | &nbsp;&nbsp; 3749487 |
| **Reinsurance-1.14%** | **Reinsurance-1.14%** | **Reinsurance-1.14%** |
| SiriusPoint Ltd. (Sweden)<sup>(d)</sup> | 31187 | &nbsp;&nbsp; 636527 |
| **Retail REITs-2.93%** | **Retail REITs-2.93%** | **Retail REITs-2.93%** |
| Simon Property Group, Inc. | 8547 | &nbsp;&nbsp; 1635127 |
| **Transaction & Payment Processing Services-1.42%** | **Transaction & Payment Processing Services-1.42%** | **Transaction & Payment Processing Services-1.42%** |
| Sezzle, Inc.<sup>(b)(d)</sup> | 12565 | &nbsp;&nbsp; 794611 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $50,847,527) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $50,847,527) | &nbsp;&nbsp; 55852240 |
| **Money Market Funds-0.17%** | **Money Market Funds-0.17%** | **Money Market Funds-0.17%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(c)(e)</sup> <br>(Cost $98,449)<br>| 98449 | &nbsp;&nbsp; 98449 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.16% <br>(Cost $50,945,976) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.16% <br>(Cost $50,945,976) | &nbsp;&nbsp; 55950689 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-6.90%** | **Money Market Funds-6.90%** | **Money Market Funds-6.90%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(c)(e)(f)</sup><br>| 1071677 | &nbsp;&nbsp; 1071677 |
| Invesco Private Prime Fund, 3.80%<sup>(c)(e)(f)</sup> | 2780591 | &nbsp;&nbsp; 2781425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $3,853,102) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $3,853,102) | &nbsp;&nbsp; 3853102 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-107.06% <br>(Cost $54,799,078) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-107.06% <br>(Cost $54,799,078) | &nbsp;&nbsp; 59803791 |
| OTHER ASSETS LESS LIABILITIES-(7.06)% | OTHER ASSETS LESS LIABILITIES-(7.06)% | &nbsp;&nbsp; (3946329)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $55857462 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Investment Abbreviations: <br> REIT -Real Estate Investment Trust

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(c)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Financial Momentum ETF (PFI)—(continued)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| &nbsp;&nbsp; Invesco Ltd. | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $1415541 | &nbsp;&nbsp;&nbsp; $(2099)<br>| &nbsp;&nbsp;&nbsp; $54519 | &nbsp;&nbsp;&nbsp; $23 | &nbsp;&nbsp;&nbsp; $1467984 | &nbsp;&nbsp;&nbsp; $- |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, Institutional <br> Class<br>| &nbsp;&nbsp;&nbsp; 111055 | &nbsp;&nbsp;&nbsp; 937691 | &nbsp;&nbsp;&nbsp; (950297)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 98449 | &nbsp;&nbsp;&nbsp; 3947 |
| **Investments Purchased with** <br> **Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private Government <br> Fund<br>| &nbsp;&nbsp;&nbsp; 1434044 | &nbsp;&nbsp;&nbsp; 27003828 | &nbsp;&nbsp;&nbsp; (27366195)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 1071677 | &nbsp;&nbsp;&nbsp; 44,876<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 3740392 | &nbsp;&nbsp;&nbsp; 57520052 | &nbsp;&nbsp;&nbsp; (58479991)<br>| &nbsp;&nbsp;&nbsp; 90 | &nbsp;&nbsp;&nbsp; 882 | &nbsp;&nbsp;&nbsp; 2781425 | &nbsp;&nbsp;&nbsp; 122,328<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $5285491 | &nbsp;&nbsp;&nbsp; $86877112 | &nbsp;&nbsp;&nbsp; $(86798582)<br>| &nbsp;&nbsp;&nbsp; $54609 | &nbsp;&nbsp;&nbsp; $905 | &nbsp;&nbsp;&nbsp; $5419535 | &nbsp;&nbsp;&nbsp; $171151 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(d)</sup> Non-income producing security.

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026.

<sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned. 

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Healthcare Momentum ETF (PTH)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-100.05%** | **Common Stocks & Other Equity Interests-100.05%** | **Common Stocks & Other Equity Interests-100.05%** |
| **Biotechnology-60.19%** | **Biotechnology-60.19%** | **Biotechnology-60.19%** |
| AnaptysBio, Inc.<sup>(b)(c)</sup> | 17433 | &nbsp;&nbsp; $826499 |
| Annexon, Inc.<sup>(b)(c)</sup> | 149595 | &nbsp;&nbsp; 933473 |
| Arcutis Biotherapeutics, Inc.<sup>(b)</sup> | 64211 | &nbsp;&nbsp; 1629033 |
| Arrowhead Pharmaceuticals, Inc.<sup>(b)</sup> | 73173 | &nbsp;&nbsp; 5073084 |
| BridgeBio Pharma, Inc.<sup>(b)(c)</sup> | 39428 | &nbsp;&nbsp; 3046602 |
| Celcuity, Inc.<sup>(b)(c)</sup> | 31368 | &nbsp;&nbsp; 3432287 |
| Cogent Biosciences, Inc.<sup>(b)(c)</sup> | 76829 | &nbsp;&nbsp; 2758929 |
| Ideaya Biosciences, Inc.<sup>(b)(c)</sup> | 43358 | &nbsp;&nbsp; 1395694 |
| Immunome, Inc.<sup>(b)(c)</sup> | 75314 | &nbsp;&nbsp; 1854231 |
| Kodiak Sciences, Inc.<sup>(b)(c)</sup> | 49083 | &nbsp;&nbsp; 1117620 |
| Kymera Therapeutics, Inc.<sup>(b)(c)</sup> | 18557 | &nbsp;&nbsp; 1348908 |
| Lexeo Therapeutics, Inc.<sup>(b)(c)</sup> | 100460 | &nbsp;&nbsp; 744409 |
| Madrigal Pharmaceuticals, Inc.<sup>(b)</sup> | 5820 | &nbsp;&nbsp; 2847784 |
| Mirum Pharmaceuticals, Inc.<sup>(b)(c)</sup> | 17506 | &nbsp;&nbsp; 1806969 |
| Monte Rosa Therapeutics, Inc.<sup>(b)</sup> | 51721 | &nbsp;&nbsp; 1061315 |
| Natera, Inc.<sup>(b)</sup> | 18625 | &nbsp;&nbsp; 4304983 |
| Oruka Therapeutics, Inc.<sup>(b)(c)</sup> | 28102 | &nbsp;&nbsp; 961931 |
| Palvella Therapeutics, Inc.<sup>(b)(c)</sup> | 13210 | &nbsp;&nbsp; 1013075 |
| Praxis Precision Medicines, Inc.<sup>(b)(c)</sup> | 20476 | &nbsp;&nbsp; 6429464 |
| Precigen, Inc.<sup>(b)(c)</sup> | 254373 | &nbsp;&nbsp; 1142135 |
| Protagonist Therapeutics, Inc.<sup>(b)</sup> | 28303 | &nbsp;&nbsp; 2315185 |
| PTC Therapeutics, Inc.<sup>(b)</sup> | 21303 | &nbsp;&nbsp; 1609016 |
| RAPT Therapeutics, Inc.<sup>(b)(c)</sup> | 27749 | &nbsp;&nbsp; 1600562 |
| Relay Therapeutics, Inc.<sup>(b)(c)</sup> | 99689 | &nbsp;&nbsp; 763618 |
| Replimune Group, Inc.<sup>(b)(c)</sup> | 142365 | &nbsp;&nbsp; 1000826 |
| Revolution Medicines, Inc.<sup>(b)</sup> | 41373 | &nbsp;&nbsp; 4011112 |
| Roivant Sciences Ltd.<sup>(b)</sup> | 237985 | &nbsp;&nbsp; 5145236 |
| Sionna Therapeutics, Inc.<sup>(b)(c)</sup> | 23894 | &nbsp;&nbsp; 1009760 |
| Stoke Therapeutics, Inc.<sup>(b)(c)</sup> | 73472 | &nbsp;&nbsp; 2229140 |
| Taysha Gene Therapies, Inc.<sup>(b)(c)</sup> | 367229 | &nbsp;&nbsp; 1656203 |
| Travere Therapeutics, Inc.<sup>(b)(c)</sup> | 80167 | &nbsp;&nbsp; 2492392 |
| United Therapeutics Corp.<sup>(b)</sup> | 6607 | &nbsp;&nbsp; 3101920 |
| Upstream Bio, Inc.<sup>(b)(c)</sup> | 31208 | &nbsp;&nbsp; 969945 |
| Zenas Biopharma, Inc.<sup>(b)(c)</sup> | 29559 | &nbsp;&nbsp; 542999 |
| Zymeworks, Inc.<sup>(b)</sup> | 36225 | &nbsp;&nbsp; 816149 |
|  |  | &nbsp;&nbsp; 72992488 |
| **Health Care Equipment-2.82%** | **Health Care Equipment-2.82%** | **Health Care Equipment-2.82%** |
| Alphatec Holdings, Inc.<sup>(b)(c)</sup> | 93325 | &nbsp;&nbsp; 1384010 |
| Artivion, Inc.<sup>(b)</sup> | 18790 | &nbsp;&nbsp; 766068 |
| Axogen, Inc.<sup>(b)</sup> | 36410 | &nbsp;&nbsp; 1268889 |
|  |  | &nbsp;&nbsp; 3418967 |
| **Health Care Facilities-9.30%** | **Health Care Facilities-9.30%** | **Health Care Facilities-9.30%** |
| Ensign Group, Inc. (The) | 13319 | &nbsp;&nbsp; 2286340 |
| HCA Healthcare, Inc. | 7064 | &nbsp;&nbsp; 3449139 |
| PACS Group, Inc.<sup>(b)(c)</sup> | 57608 | &nbsp;&nbsp; 1944846 |
| Tenet Healthcare Corp.<sup>(b)</sup> | 19008 | &nbsp;&nbsp; 3597834 |
|  |  | &nbsp;&nbsp; 11278159 |
| **Health Care Services-6.34%** | **Health Care Services-6.34%** | **Health Care Services-6.34%** |
| BrightSpring Health Services, Inc.<sup>(b)(c)</sup> | 58168 | &nbsp;&nbsp; 2284257 |
| Guardant Health, Inc.<sup>(b)</sup> | 47375 | &nbsp;&nbsp; 5402645 |
|  |  | &nbsp;&nbsp; 7686902 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Life Sciences Tools & Services-3.45%** | **Life Sciences Tools & Services-3.45%** | **Life Sciences Tools & Services-3.45%** |
| Fortrea Holdings, Inc.<sup>(b)</sup> | 46232 | &nbsp;&nbsp; $777160 |
| Medpace Holdings, Inc.<sup>(b)</sup> | 5853 | &nbsp;&nbsp; 3409255 |
|  |  | &nbsp;&nbsp; 4186415 |
| **Managed Health Care-1.76%** | **Managed Health Care-1.76%** | **Managed Health Care-1.76%** |
| Alignment Healthcare, Inc.<sup>(b)</sup> | 94994 | &nbsp;&nbsp; 2140215 |
| **Pharmaceuticals-16.19%** | **Pharmaceuticals-16.19%** | **Pharmaceuticals-16.19%** |
| Amneal Pharmaceuticals, Inc.<sup>(b)</sup> | 95448 | &nbsp;&nbsp; 1305729 |
| Axsome Therapeutics, Inc.<sup>(b)</sup> | 19077 | &nbsp;&nbsp; 3514937 |
| EyePoint, Inc.<sup>(b)(c)</sup> | 45221 | &nbsp;&nbsp; 611388 |
| Harrow, Inc.<sup>(b)(c)</sup> | 48921 | &nbsp;&nbsp; 2002826 |
| Ligand Pharmaceuticals, Inc.<sup>(b)</sup> | 7514 | &nbsp;&nbsp; 1443439 |
| Maze Therapeutics, Inc.<sup>(b)(c)</sup> | 23056 | &nbsp;&nbsp; 1004780 |
| Nuvation Bio, Inc.<sup>(b)(c)</sup> | 270074 | &nbsp;&nbsp; 1415188 |
| Phathom Pharmaceuticals, Inc.<sup>(b)(c)</sup> | 64506 | &nbsp;&nbsp; 881797 |
| Tarsus Pharmaceuticals, Inc.<sup>(b)</sup> | 21290 | &nbsp;&nbsp; 1374057 |
| Terns Pharmaceuticals, Inc.<sup>(b)(c)</sup> | 146784 | &nbsp;&nbsp; 5078726 |
| Trevi Therapeutics, Inc.<sup>(b)(c)</sup> | 95081 | &nbsp;&nbsp; 995498 |
|  |  | &nbsp;&nbsp; 19628365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $106,240,002) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $106,240,002) | &nbsp;&nbsp; 121331511 |
| **Money Market Funds-0.13%** | **Money Market Funds-0.13%** | **Money Market Funds-0.13%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(d)(e)</sup> <br>(Cost $162,791)<br>| 162791 | &nbsp;&nbsp; 162791 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.18% <br>(Cost $106,402,793) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.18% <br>(Cost $106,402,793) | &nbsp;&nbsp; 121494302 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-32.18%** | **Money Market Funds-32.18%** | **Money Market Funds-32.18%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(d)(e)(f)</sup><br>| 12272488 | &nbsp;&nbsp; 12272488 |
| Invesco Private Prime Fund, 3.80%<sup>(d)(e)(f)</sup> | 26742323 | &nbsp;&nbsp; 26750346 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $39,022,834) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $39,022,834) | &nbsp;&nbsp; 39022834 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-132.36% <br>(Cost $145,425,627) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-132.36% <br>(Cost $145,425,627) | &nbsp;&nbsp; 160517136 |
| OTHER ASSETS LESS LIABILITIES-(32.36)% | OTHER ASSETS LESS LIABILITIES-(32.36)% | &nbsp;&nbsp; (39240157)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $121276979 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Healthcare Momentum ETF (PTH)—(continued)**

January 31, 2026

*(Unaudited)*

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain** <br>**(Loss)**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $249261 | &nbsp;&nbsp;&nbsp; $4549497 | &nbsp;&nbsp;&nbsp; $(4635967)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $162791 | &nbsp;&nbsp;&nbsp; $7988 |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; 9815269 | &nbsp;&nbsp;&nbsp; 54371623 | &nbsp;&nbsp;&nbsp; (51914404)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 12272488 | &nbsp;&nbsp;&nbsp; 220,017<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 25531198 | &nbsp;&nbsp;&nbsp; 112411380 | &nbsp;&nbsp;&nbsp; (111193642)<br>| &nbsp;&nbsp;&nbsp; 1780 | &nbsp;&nbsp;&nbsp; (370)<br>| &nbsp;&nbsp;&nbsp; 26750346 | &nbsp;&nbsp;&nbsp; 593,891<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $35595728 | &nbsp;&nbsp;&nbsp; $171332500 | &nbsp;&nbsp;&nbsp; $(167744013)<br>| &nbsp;&nbsp;&nbsp; $1780 | &nbsp;&nbsp;&nbsp; $(370)<br>| &nbsp;&nbsp;&nbsp; $39185625 | &nbsp;&nbsp;&nbsp; $821896 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Industrials Momentum ETF (PRN)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-100.04%** | **Common Stocks & Other Equity Interests-100.04%** | **Common Stocks & Other Equity Interests-100.04%** |
| **Aerospace & Defense-18.61%** | **Aerospace & Defense-18.61%** | **Aerospace & Defense-18.61%** |
| Astronics Corp.<sup>(b)(c)</sup> | 85233 | &nbsp;&nbsp; $6456400 |
| Curtiss-Wright Corp. | 14705 | &nbsp;&nbsp; 9656626 |
| General Electric Co. | 32453 | &nbsp;&nbsp; 9956256 |
| HEICO Corp.<sup>(c)</sup> | 22827 | &nbsp;&nbsp; 7553683 |
| Howmet Aerospace, Inc. | 76544 | &nbsp;&nbsp; 15927276 |
| Moog, Inc., Class A | 15590 | &nbsp;&nbsp; 4760406 |
| Woodward, Inc. | 21005 | &nbsp;&nbsp; 6676229 |
|  |  | &nbsp;&nbsp; 60986876 |
| **Building Products-1.41%** | **Building Products-1.41%** | **Building Products-1.41%** |
| CSW Industrials, Inc. | 17103 | &nbsp;&nbsp; 4617468 |
| **Cargo Ground Transportation-1.48%** | **Cargo Ground Transportation-1.48%** | **Cargo Ground Transportation-1.48%** |
| Ryder System, Inc. | 25442 | &nbsp;&nbsp; 4866546 |
| **Construction & Engineering-28.31%** | **Construction & Engineering-28.31%** | **Construction & Engineering-28.31%** |
| API Group Corp.<sup>(b)</sup> | 150822 | &nbsp;&nbsp; 6269671 |
| Comfort Systems USA, Inc. | 17369 | &nbsp;&nbsp; 19837135 |
| Dycom Industries, Inc.<sup>(b)</sup> | 25627 | &nbsp;&nbsp; 9338223 |
| Everus Construction Group, Inc.<sup>(b)</sup> | 39115 | &nbsp;&nbsp; 3461286 |
| Granite Construction, Inc. | 51537 | &nbsp;&nbsp; 6222577 |
| IES Holdings, Inc.<sup>(b)(c)</sup> | 8613 | &nbsp;&nbsp; 3275438 |
| MasTec, Inc.<sup>(b)</sup> | 35763 | &nbsp;&nbsp; 8600286 |
| MYR Group, Inc.<sup>(b)</sup> | 14686 | &nbsp;&nbsp; 3672087 |
| Primoris Services Corp. | 45815 | &nbsp;&nbsp; 6792074 |
| Quanta Services, Inc. | 34806 | &nbsp;&nbsp; 16519972 |
| Tutor Perini Corp. | 111337 | &nbsp;&nbsp; 8783376 |
|  |  | &nbsp;&nbsp; 92772125 |
| **Construction Machinery & Heavy Transportation Equipment-8.72%** | **Construction Machinery & Heavy Transportation Equipment-8.72%** | **Construction Machinery & Heavy Transportation Equipment-8.72%** |
| Allison Transmission Holdings, Inc. | 34056 | &nbsp;&nbsp; 3701887 |
| Blue Bird Corp.<sup>(b)(c)</sup> | 53284 | &nbsp;&nbsp; 2680718 |
| Caterpillar, Inc. | 15464 | &nbsp;&nbsp; 10165415 |
| Cummins, Inc. | 20754 | &nbsp;&nbsp; 12012830 |
|  |  | &nbsp;&nbsp; 28560850 |
| **Construction Materials-2.11%** | **Construction Materials-2.11%** | **Construction Materials-2.11%** |
| CRH PLC | 56554 | &nbsp;&nbsp; 6922775 |
| **Diversified Support Services-2.34%** | **Diversified Support Services-2.34%** | **Diversified Support Services-2.34%** |
| VSE Corp. | 35054 | &nbsp;&nbsp; 7661753 |
| **Electrical Components & Equipment-6.51%** | **Electrical Components & Equipment-6.51%** | **Electrical Components & Equipment-6.51%** |
| Acuity, Inc. | 8650 | &nbsp;&nbsp; 2674926 |
| Sunrun, Inc.<sup>(b)</sup> | 418347 | &nbsp;&nbsp; 7948593 |
| T1 Energy, Inc. (Norway)<sup>(b)</sup> | 574628 | &nbsp;&nbsp; 4786651 |
| Vicor Corp.<sup>(b)(c)</sup> | 37465 | &nbsp;&nbsp; 5907107 |
|  |  | &nbsp;&nbsp; 21317277 |
| **Electronic Components-1.06%** | **Electronic Components-1.06%** | **Electronic Components-1.06%** |
| Bel Fuse, Inc., Class B<sup>(c)</sup> | 17277 | &nbsp;&nbsp; 3475960 |
| **Electronic Equipment & Instruments-2.29%** | **Electronic Equipment & Instruments-2.29%** | **Electronic Equipment & Instruments-2.29%** |
| Advanced Energy Industries, Inc. | 16225 | &nbsp;&nbsp; 4143216 |
| OSI Systems, Inc.<sup>(b)</sup> | 13376 | &nbsp;&nbsp; 3345873 |
|  |  | &nbsp;&nbsp; 7489089 |
| **Electronic Manufacturing Services-6.01%** | **Electronic Manufacturing Services-6.01%** | **Electronic Manufacturing Services-6.01%** |
| Jabil, Inc. | 49737 | &nbsp;&nbsp; 11797119 |
| TE Connectivity PLC (Switzerland) | 35509 | &nbsp;&nbsp; 7910695 |
|  |  | &nbsp;&nbsp; 19707814 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Environmental & Facilities Services-1.73%** | **Environmental & Facilities Services-1.73%** | **Environmental & Facilities Services-1.73%** |
| CECO Environmental Corp.<sup>(b)(c)</sup> | 42853 | &nbsp;&nbsp; $2889578 |
| Enviri Corp.<sup>(b)(c)</sup> | 146716 | &nbsp;&nbsp; 2775866 |
|  |  | &nbsp;&nbsp; 5665444 |
| **Industrial Machinery & Supplies & Components-9.49%** | **Industrial Machinery & Supplies & Components-9.49%** | **Industrial Machinery & Supplies & Components-9.49%** |
| Enpro, Inc. | 17949 | &nbsp;&nbsp; 4285862 |
| ITT, Inc. | 22507 | &nbsp;&nbsp; 4103025 |
| Mueller Industries, Inc. | 54270 | &nbsp;&nbsp; 7388318 |
| Parker-Hannifin Corp. | 8943 | &nbsp;&nbsp; 8369217 |
| SPX Technologies, Inc.<sup>(b)</sup> | 21707 | &nbsp;&nbsp; 4523956 |
| Standex International Corp. | 10058 | &nbsp;&nbsp; 2413920 |
|  |  | &nbsp;&nbsp; 31084298 |
| **Research & Consulting Services-7.48%** | **Research & Consulting Services-7.48%** | **Research & Consulting Services-7.48%** |
| Huron Consulting Group, Inc.<sup>(b)</sup> | 13528 | &nbsp;&nbsp; 2286232 |
| Planet Labs PBC<sup>(b)(c)</sup> | 651022 | &nbsp;&nbsp; 16256019 |
| Resolute Holdings Management, Inc.<sup>(b)(c)</sup> | 13500 | &nbsp;&nbsp; 2753460 |
| Willdan Group, Inc.<sup>(b)</sup> | 25540 | &nbsp;&nbsp; 3223148 |
|  |  | &nbsp;&nbsp; 24518859 |
| **Technology Hardware, Storage & Peripherals-0.80%** | **Technology Hardware, Storage & Peripherals-0.80%** | **Technology Hardware, Storage & Peripherals-0.80%** |
| Diebold Nixdorf, Inc.<sup>(b)(c)</sup> | 37799 | &nbsp;&nbsp; 2608509 |
| **Trading Companies & Distributors-1.69%** | **Trading Companies & Distributors-1.69%** | **Trading Companies & Distributors-1.69%** |
| Xometry, Inc., Class A<sup>(b)(c)</sup> | 96739 | &nbsp;&nbsp; 5526699 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $257,737,837) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $257,737,837) | &nbsp;&nbsp; 327782342 |
| **Money Market Funds-0.08%** | **Money Market Funds-0.08%** | **Money Market Funds-0.08%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(d)(e)</sup> <br>(Cost $250,354)<br>| 250354 | &nbsp;&nbsp; 250354 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.12% <br>(Cost $257,988,191) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.12% <br>(Cost $257,988,191) | &nbsp;&nbsp; 328032696 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-12.08%** | **Money Market Funds-12.08%** | **Money Market Funds-12.08%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(d)(e)(f)</sup><br>| 11000617 | &nbsp;&nbsp; 11000617 |
| Invesco Private Prime Fund, 3.80%<sup>(d)(e)(f)</sup> | 28583699 | &nbsp;&nbsp; 28592274 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $39,592,891) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $39,592,891) | &nbsp;&nbsp; 39592891 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-112.20% <br>(Cost $297,581,082) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-112.20% <br>(Cost $297,581,082) | &nbsp;&nbsp; 367625587 |
| OTHER ASSETS LESS LIABILITIES-(12.20)% | OTHER ASSETS LESS LIABILITIES-(12.20)% | &nbsp;&nbsp; (39960977)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $327664610 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Industrials Momentum ETF (PRN)—(continued)**

January 31, 2026

*(Unaudited)*

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $576679 | &nbsp;&nbsp;&nbsp; $2865958 | &nbsp;&nbsp;&nbsp; $(3192283)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $250354 | &nbsp;&nbsp;&nbsp; $12847 |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; 19440781 | &nbsp;&nbsp;&nbsp; 136478962 | &nbsp;&nbsp;&nbsp; (144919126)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 11000617 | &nbsp;&nbsp;&nbsp; 432,924<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 50461913 | &nbsp;&nbsp;&nbsp; 307766833 | &nbsp;&nbsp;&nbsp; (329641526)<br>| &nbsp;&nbsp;&nbsp; 855 | &nbsp;&nbsp;&nbsp; 4199 | &nbsp;&nbsp;&nbsp; 28592274 | &nbsp;&nbsp;&nbsp; 1,166,756<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $70479373 | &nbsp;&nbsp;&nbsp; $447111753 | &nbsp;&nbsp;&nbsp; $(477752935)<br>| &nbsp;&nbsp;&nbsp; $855 | &nbsp;&nbsp;&nbsp; $4199 | &nbsp;&nbsp;&nbsp; $39843245 | &nbsp;&nbsp;&nbsp; $1612527 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Technology Momentum ETF (PTF)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-100.03%** | **Common Stocks & Other Equity Interests-100.03%** | **Common Stocks & Other Equity Interests-100.03%** |
| **Application Software-8.97%** | **Application Software-8.97%** | **Application Software-8.97%** |
| AppLovin Corp., Class A<sup>(b)</sup> | 13943 | &nbsp;&nbsp; $6596573 |
| Clear Secure, Inc., Class A<sup>(c)</sup> | 218860 | &nbsp;&nbsp; 7139213 |
| Digital Turbine, Inc.<sup>(b)(c)</sup> | 1385956 | &nbsp;&nbsp; 7234690 |
| InterDigital, Inc.<sup>(c)</sup> | 28245 | &nbsp;&nbsp; 9220298 |
| Pegasystems, Inc.<sup>(c)</sup> | 132298 | &nbsp;&nbsp; 5780100 |
|  |  | &nbsp;&nbsp; 35970874 |
| **Communications Equipment-16.72%** | **Communications Equipment-16.72%** | **Communications Equipment-16.72%** |
| Ciena Corp.<sup>(b)(c)</sup> | 56120 | &nbsp;&nbsp; 14131577 |
| Lumentum Holdings, Inc.<sup>(b)(c)</sup> | 36507 | &nbsp;&nbsp; 14304903 |
| Ondas, Inc.<sup>(b)(c)</sup> | 1706346 | &nbsp;&nbsp; 17677745 |
| Viavi Solutions, Inc.<sup>(b)</sup> | 462357 | &nbsp;&nbsp; 11309252 |
| Vistance Networks, Inc.<sup>(b)(c)</sup> | 534878 | &nbsp;&nbsp; 9627804 |
|  |  | &nbsp;&nbsp; 67051281 |
| **Electronic Components-9.14%** | **Electronic Components-9.14%** | **Electronic Components-9.14%** |
| Amphenol Corp., Class A | 74983 | &nbsp;&nbsp; 10803550 |
| Coherent Corp.<sup>(b)</sup> | 66727 | &nbsp;&nbsp; 14158135 |
| Corning, Inc. | 113439 | &nbsp;&nbsp; 11712577 |
|  |  | &nbsp;&nbsp; 36674262 |
| **Electronic Equipment & Instruments-2.45%** | **Electronic Equipment & Instruments-2.45%** | **Electronic Equipment & Instruments-2.45%** |
| nLight, Inc.<sup>(b)</sup> | 215250 | &nbsp;&nbsp; 9817552 |
| **Interactive Media & Services-5.08%** | **Interactive Media & Services-5.08%** | **Interactive Media & Services-5.08%** |
| Alphabet, Inc., Class A | 30560 | &nbsp;&nbsp; 10329280 |
| Reddit, Inc., Class A<sup>(b)</sup> | 55765 | &nbsp;&nbsp; 10052757 |
|  |  | &nbsp;&nbsp; 20382037 |
| **IT Consulting & Other Services-2.29%** | **IT Consulting & Other Services-2.29%** | **IT Consulting & Other Services-2.29%** |
| International Business Machines Corp. | 29995 | &nbsp;&nbsp; 9199467 |
| **Semiconductor Materials & Equipment-13.81%** | **Semiconductor Materials & Equipment-13.81%** | **Semiconductor Materials & Equipment-13.81%** |
| ACM Research, Inc., Class A<sup>(b)</sup> | 213645 | &nbsp;&nbsp; 12417047 |
| KLA Corp. | 11722 | &nbsp;&nbsp; 16738313 |
| Lam Research Corp. | 59970 | &nbsp;&nbsp; 14000596 |
| Teradyne, Inc. | 50737 | &nbsp;&nbsp; 12230154 |
|  |  | &nbsp;&nbsp; 55386110 |
| **Semiconductors-25.87%** | **Semiconductors-25.87%** | **Semiconductors-25.87%** |
| Broadcom, Inc. | 36627 | &nbsp;&nbsp; 12134525 |
| First Solar, Inc.<sup>(b)</sup> | 34424 | &nbsp;&nbsp; 7763300 |
| Intel Corp.<sup>(b)</sup> | 256398 | &nbsp;&nbsp; 11914815 |
| &nbsp;&nbsp;&nbsp; MACOM Technology Solutions Holdings, <br> Inc.<sup>(b)(c)</sup><br>| 53835 | &nbsp;&nbsp; 11793095 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Semiconductors-(continued)** | **Semiconductors-(continued)** | **Semiconductors-(continued)** |
| Micron Technology, Inc. | 40568 | &nbsp;&nbsp; $16830852 |
| NVIDIA Corp. | 117204 | &nbsp;&nbsp; 22401201 |
| Semtech Corp.<sup>(b)</sup> | 113111 | &nbsp;&nbsp; 9020602 |
| SiTime Corp.<sup>(b)(c)</sup> | 32690 | &nbsp;&nbsp; 11870066 |
|  |  | &nbsp;&nbsp; 103728456 |
| **Technology Hardware, Storage & Peripherals-15.70%** | **Technology Hardware, Storage & Peripherals-15.70%** | **Technology Hardware, Storage & Peripherals-15.70%** |
| Apple, Inc. | 74617 | &nbsp;&nbsp; 19361619 |
| GPGI, Inc., Class A<sup>(b)(c)</sup> | 417138 | &nbsp;&nbsp; 9831942 |
| Seagate Technology Holdings PLC | 40020 | &nbsp;&nbsp; 16315754 |
| Western Digital Corp. | 69673 | &nbsp;&nbsp; 17434275 |
|  |  | &nbsp;&nbsp; 62943590 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $315,954,380) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $315,954,380) | &nbsp;&nbsp; 401153629 |
| **Money Market Funds-0.09%** | **Money Market Funds-0.09%** | **Money Market Funds-0.09%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(d)(e)</sup> <br>(Cost $336,939)<br>| 336939 | &nbsp;&nbsp; 336939 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.12% <br>(Cost $316,291,319) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.12% <br>(Cost $316,291,319) | &nbsp;&nbsp; 401490568 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-15.12%** | **Money Market Funds-15.12%** | **Money Market Funds-15.12%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(d)(e)(f)</sup><br>| 17209905 | &nbsp;&nbsp; 17209905 |
| Invesco Private Prime Fund, 3.80%<sup>(d)(e)(f)</sup> | 43422972 | &nbsp;&nbsp; 43435999 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $60,645,904) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $60,645,904) | &nbsp;&nbsp; 60645904 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-115.24% <br>(Cost $376,937,223) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-115.24% <br>(Cost $376,937,223) | &nbsp;&nbsp; 462136472 |
| OTHER ASSETS LESS LIABILITIES-(15.24)% | OTHER ASSETS LESS LIABILITIES-(15.24)% | &nbsp;&nbsp; (61104065)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $401032407 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $285703 | &nbsp;&nbsp;&nbsp; $4727625 | &nbsp;&nbsp;&nbsp; $(4676389)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $336939 | &nbsp;&nbsp;&nbsp; $12128 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Technology Momentum ETF (PTF)—(continued)**

January 31, 2026

*(Unaudited)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value**<br> **April 30, 2025**<br>| **Purchases**<br> **at Cost**<br>| **Proceeds**<br> **from Sales**<br>| **Change in**<br> **Unrealized**<br> **Appreciation**<br>| **Realized**<br> **Gain**<br>| **Value**<br> **January 31, 2026**<br>| **Dividend Income** |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; $16989874 | &nbsp;&nbsp;&nbsp; $256207862 | &nbsp;&nbsp;&nbsp; $(255987831)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $17209905 | &nbsp;&nbsp;&nbsp; $635,616<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 44155951 | &nbsp;&nbsp;&nbsp; 468559739 | &nbsp;&nbsp;&nbsp; (469282470)<br>| &nbsp;&nbsp;&nbsp; 1801 | &nbsp;&nbsp;&nbsp; 978 | &nbsp;&nbsp;&nbsp; 43435999 | &nbsp;&nbsp;&nbsp; 1,745,128<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $61431528 | &nbsp;&nbsp;&nbsp; $729495226 | &nbsp;&nbsp;&nbsp; $(729946690)<br>| &nbsp;&nbsp;&nbsp; $1801 | &nbsp;&nbsp;&nbsp; $978 | &nbsp;&nbsp;&nbsp; $60982843 | &nbsp;&nbsp;&nbsp; $2392872 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco Dorsey Wright Utilities Momentum ETF (PUI)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.97%** | **Common Stocks & Other Equity Interests-99.97%** | **Common Stocks & Other Equity Interests-99.97%** |
| **Alternative Carriers-3.52%** | **Alternative Carriers-3.52%** | **Alternative Carriers-3.52%** |
| Lumen Technologies, Inc.<sup>(b)</sup> | 197158 | &nbsp;&nbsp; $1738934 |
| **Electric Utilities-39.06%** | **Electric Utilities-39.06%** | **Electric Utilities-39.06%** |
| Alliant Energy Corp. | 19461 | &nbsp;&nbsp; 1282675 |
| American Electric Power Co., Inc. | 10393 | &nbsp;&nbsp; 1244822 |
| Constellation Energy Corp. | 5269 | &nbsp;&nbsp; 1478903 |
| Duke Energy Corp. | 16196 | &nbsp;&nbsp; 1965385 |
| Entergy Corp. | 15458 | &nbsp;&nbsp; 1482268 |
| Evergy, Inc. | 17587 | &nbsp;&nbsp; 1349450 |
| Eversource Energy | 17217 | &nbsp;&nbsp; 1190211 |
| Exelon Corp. | 30162 | &nbsp;&nbsp; 1350654 |
| NRG Energy, Inc. | 11333 | &nbsp;&nbsp; 1729756 |
| Otter Tail Corp. | 12290 | &nbsp;&nbsp; 1095776 |
| PG&E Corp. | 73451 | &nbsp;&nbsp; 1132614 |
| Pinnacle West Capital Corp. | 12153 | &nbsp;&nbsp; 1137035 |
| Southern Co. (The) | 15622 | &nbsp;&nbsp; 1395201 |
| Xcel Energy, Inc. | 19202 | &nbsp;&nbsp; 1460504 |
|  |  | &nbsp;&nbsp; 19295254 |
| **Electrical Components & Equipment-2.53%** | **Electrical Components & Equipment-2.53%** | **Electrical Components & Equipment-2.53%** |
| Preformed Line Products Co.<sup>(c)</sup> | 4978 | &nbsp;&nbsp; 1249179 |
| **Gas Utilities-10.74%** | **Gas Utilities-10.74%** | **Gas Utilities-10.74%** |
| Atmos Energy Corp. | 10920 | &nbsp;&nbsp; 1816433 |
| MDU Resources Group, Inc.<sup>(c)</sup> | 55333 | &nbsp;&nbsp; 1134880 |
| National Fuel Gas Co. | 14795 | &nbsp;&nbsp; 1239081 |
| UGI Corp. | 27823 | &nbsp;&nbsp; 1115980 |
|  |  | &nbsp;&nbsp; 5306374 |
| **Heavy Electrical Equipment-3.85%** | **Heavy Electrical Equipment-3.85%** | **Heavy Electrical Equipment-3.85%** |
| GE Vernova, Inc. | 2616 | &nbsp;&nbsp; 1900184 |
| **Independent Power Producers & Energy Traders-7.65%** | **Independent Power Producers & Energy Traders-7.65%** | **Independent Power Producers & Energy Traders-7.65%** |
| AES Corp. (The) | 84120 | &nbsp;&nbsp; 1232358 |
| Talen Energy Corp.<sup>(b)</sup> | 4089 | &nbsp;&nbsp; 1424444 |
| Vistra Corp. | 7095 | &nbsp;&nbsp; 1123493 |
|  |  | &nbsp;&nbsp; 3780295 |
| **Multi-Utilities-24.01%** | **Multi-Utilities-24.01%** | **Multi-Utilities-24.01%** |
| Ameren Corp. | 11743 | &nbsp;&nbsp; 1212817 |
| CenterPoint Energy, Inc. | 32678 | &nbsp;&nbsp; 1296990 |
| CMS Energy Corp. | 18808 | &nbsp;&nbsp; 1344584 |
| DTE Energy Co. | 12218 | &nbsp;&nbsp; 1641855 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Multi-Utilities-(continued)** | **Multi-Utilities-(continued)** | **Multi-Utilities-(continued)** |
| NiSource, Inc. | 40951 | &nbsp;&nbsp; $1813720 |
| Public Service Enterprise Group, Inc. | 14420 | &nbsp;&nbsp; 1187631 |
| Sempra | 16338 | &nbsp;&nbsp; 1421569 |
| WEC Energy Group, Inc. | 17559 | &nbsp;&nbsp; 1943255 |
|  |  | &nbsp;&nbsp; 11862421 |
| **Oil & Gas Exploration & Production-2.52%** | **Oil & Gas Exploration & Production-2.52%** | **Oil & Gas Exploration & Production-2.52%** |
| EQT Corp. | 21583 | &nbsp;&nbsp; 1245987 |
| **Oil & Gas Storage & Transportation-3.66%** | **Oil & Gas Storage & Transportation-3.66%** | **Oil & Gas Storage & Transportation-3.66%** |
| ONEOK, Inc. | 22813 | &nbsp;&nbsp; 1806561 |
| **Renewable Electricity-2.43%** | **Renewable Electricity-2.43%** | **Renewable Electricity-2.43%** |
| Ormat Technologies, Inc.<sup>(c)</sup> | 9626 | &nbsp;&nbsp; 1202672 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $43,910,820) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $43,910,820) | &nbsp;&nbsp; 49387861 |
| **Money Market Funds-0.24%** | **Money Market Funds-0.24%** | **Money Market Funds-0.24%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(d)(e)</sup> <br>(Cost $122,213)<br>| 122213 | &nbsp;&nbsp; 122213 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.21% <br>(Cost $44,033,033) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-100.21% <br>(Cost $44,033,033) | &nbsp;&nbsp; 49510074 |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-6.31%** | **Money Market Funds-6.31%** | **Money Market Funds-6.31%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(d)(e)(f)</sup><br>| 867624 | &nbsp;&nbsp; 867624 |
| Invesco Private Prime Fund, 3.80%<sup>(d)(e)(f)</sup> | 2248710 | &nbsp;&nbsp; 2249385 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $3,117,009) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $3,117,009) | &nbsp;&nbsp; 3117009 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-106.52% <br>(Cost $47,150,042) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-106.52% <br>(Cost $47,150,042) | &nbsp;&nbsp; 52627083 |
| OTHER ASSETS LESS LIABILITIES-(6.52)% | OTHER ASSETS LESS LIABILITIES-(6.52)% | &nbsp;&nbsp; (3223173)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $49403910 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $94565 | &nbsp;&nbsp;&nbsp; $1855037 | &nbsp;&nbsp;&nbsp; $(1827389)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $122213 | &nbsp;&nbsp;&nbsp; $3305 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco Dorsey Wright Utilities Momentum ETF (PUI)—(continued)**

January 31, 2026

*(Unaudited)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value**<br> **April 30, 2025**<br>| **Purchases**<br> **at Cost**<br>| **Proceeds**<br> **from Sales**<br>| **Change in**<br> **Unrealized**<br> **Appreciation**<br>| **Realized**<br> **Gain**<br>| **Value**<br> **January 31, 2026**<br>| **Dividend Income** |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; $2519060 | &nbsp;&nbsp;&nbsp; $29281192 | &nbsp;&nbsp;&nbsp; $(30932628)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $867624 | &nbsp;&nbsp;&nbsp; $57,400<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 6535402 | &nbsp;&nbsp;&nbsp; 71107330 | &nbsp;&nbsp;&nbsp; (75395291)<br>| &nbsp;&nbsp;&nbsp; 156 | &nbsp;&nbsp;&nbsp; 1788 | &nbsp;&nbsp;&nbsp; 2249385 | &nbsp;&nbsp;&nbsp; 155,575<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $9149027 | &nbsp;&nbsp;&nbsp; $102243559 | &nbsp;&nbsp;&nbsp; $(108155308)<br>| &nbsp;&nbsp;&nbsp; $156 | &nbsp;&nbsp;&nbsp; $1788 | &nbsp;&nbsp;&nbsp; $3239222 | &nbsp;&nbsp;&nbsp; $216280 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco NASDAQ Internet ETF (PNQI)**

January 31, 2026

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.97%** | **Common Stocks & Other Equity Interests-99.97%** | **Common Stocks & Other Equity Interests-99.97%** |
| **Advertising-0.03%** | **Advertising-0.03%** | **Advertising-0.03%** |
| Criteo S.A., ADR (France)<sup>(b)</sup> | 9757 | &nbsp;&nbsp; $187042 |
| **Apparel Retail-0.03%** | **Apparel Retail-0.03%** | **Apparel Retail-0.03%** |
| Lands' End, Inc.<sup>(b)(c)</sup> | 5432 | &nbsp;&nbsp; 96472 |
| Stitch Fix, Inc., Class A<sup>(b)(c)</sup> | 21065 | &nbsp;&nbsp; 101112 |
|  |  | &nbsp;&nbsp; 197584 |
| **Application Software-8.92%** | **Application Software-8.92%** | **Application Software-8.92%** |
| Adobe, Inc.<sup>(b)</sup> | 74275 | &nbsp;&nbsp; 21781144 |
| Alarm.com Holdings, Inc.<sup>(b)</sup> | 8826 | &nbsp;&nbsp; 430532 |
| Box, Inc., Class A<sup>(b)(c)</sup> | 25676 | &nbsp;&nbsp; 650887 |
| Consensus Cloud Solutions, Inc.<sup>(b)(c)</sup> | 3324 | &nbsp;&nbsp; 71001 |
| DocuSign, Inc.<sup>(b)</sup> | 35728 | &nbsp;&nbsp; 1877149 |
| Dropbox, Inc., Class A<sup>(b)(c)</sup> | 32410 | &nbsp;&nbsp; 825807 |
| Open Text Corp. (Canada) | 44753 | &nbsp;&nbsp; 1142544 |
| Salesforce, Inc. | 122634 | &nbsp;&nbsp; 26033972 |
| SPS Commerce, Inc.<sup>(b)</sup> | 6706 | &nbsp;&nbsp; 598577 |
| Unity Software, Inc.<sup>(b)</sup> | 75959 | &nbsp;&nbsp; 2210407 |
| Zoom Communications, Inc., Class A<sup>(b)</sup> | 47141 | &nbsp;&nbsp; 4341686 |
|  |  | &nbsp;&nbsp; 59963706 |
| **Broadline Retail-16.80%** | **Broadline Retail-16.80%** | **Broadline Retail-16.80%** |
| Alibaba Group Holding Ltd., ADR (China)<sup>(c)</sup> | 98290 | &nbsp;&nbsp; 16666053 |
| Amazon.com, Inc.<sup>(b)</sup> | 242547 | &nbsp;&nbsp; 58041497 |
| Coupang, Inc. (South Korea)<sup>(b)</sup> | 296261 | &nbsp;&nbsp; 5972622 |
| eBay, Inc. | 80265 | &nbsp;&nbsp; 7321773 |
| Etsy, Inc.<sup>(b)</sup> | 17565 | &nbsp;&nbsp; 930242 |
| Global-e Online Ltd. (Israel)<sup>(b)</sup> | 30128 | &nbsp;&nbsp; 1101179 |
| JD.com, Inc., ADR (China) | 84915 | &nbsp;&nbsp; 2418379 |
| MercadoLibre, Inc. (Brazil)<sup>(b)</sup> | 8984 | &nbsp;&nbsp; 19295745 |
| Vipshop Holdings Ltd., ADR (China) | 72721 | &nbsp;&nbsp; 1244256 |
|  |  | &nbsp;&nbsp; 112991746 |
| **Casinos & Gaming-0.36%** | **Casinos & Gaming-0.36%** | **Casinos & Gaming-0.36%** |
| DraftKings, Inc., Class A<sup>(b)(c)</sup> | 88414 | &nbsp;&nbsp; 2432269 |
| **Commercial Printing-0.05%** | **Commercial Printing-0.05%** | **Commercial Printing-0.05%** |
| Cimpress PLC (Ireland)<sup>(b)(c)</sup> | 4419 | &nbsp;&nbsp; 349499 |
| **Financial Exchanges & Data-1.17%** | **Financial Exchanges & Data-1.17%** | **Financial Exchanges & Data-1.17%** |
| Coinbase Global, Inc., Class A<sup>(b)</sup> | 40495 | &nbsp;&nbsp; 7885996 |
| **Health Care Technology-0.03%** | **Health Care Technology-0.03%** | **Health Care Technology-0.03%** |
| GoodRx Holdings, Inc., Class A<sup>(b)(c)</sup> | 18756 | &nbsp;&nbsp; 42576 |
| Teladoc Health, Inc.<sup>(b)(c)</sup> | 31509 | &nbsp;&nbsp; 171724 |
|  |  | &nbsp;&nbsp; 214300 |
| **Homefurnishing Retail-0.30%** | **Homefurnishing Retail-0.30%** | **Homefurnishing Retail-0.30%** |
| Bed Bath & Beyond, Inc.<sup>(b)(c)</sup> | 12259 | &nbsp;&nbsp; 72451 |
| Wayfair, Inc., Class A<sup>(b)(c)</sup> | 19010 | &nbsp;&nbsp; 1967345 |
|  |  | &nbsp;&nbsp; 2039796 |
| **Hotels, Resorts & Cruise Lines-7.08%** | **Hotels, Resorts & Cruise Lines-7.08%** | **Hotels, Resorts & Cruise Lines-7.08%** |
| Airbnb, Inc., Class A<sup>(b)</sup> | 75453 | &nbsp;&nbsp; 9761355 |
| Booking Holdings, Inc. | 5723 | &nbsp;&nbsp; 28625530 |
| Expedia Group, Inc. | 20754 | &nbsp;&nbsp; 5496489 |
| MakeMyTrip Ltd. (India)<sup>(b)(c)</sup> | 15970 | &nbsp;&nbsp; 996209 |
| Trip.com Group Ltd., ADR (China)<sup>(c)</sup> | 44172 | &nbsp;&nbsp; 2710836 |
|  |  | &nbsp;&nbsp; 47590419 |
| **Human Resource & Employment Services-0.19%** | **Human Resource & Employment Services-0.19%** | **Human Resource & Employment Services-0.19%** |
| Paylocity Holding Corp.<sup>(b)</sup> | 9696 | &nbsp;&nbsp; 1308766 |
| **Interactive Home Entertainment-4.06%** | **Interactive Home Entertainment-4.06%** | **Interactive Home Entertainment-4.06%** |
| Electronic Arts, Inc. | 44385 | &nbsp;&nbsp; 9050989 |
| NetEase, Inc., ADR (China) | 14728 | &nbsp;&nbsp; 1897409 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Interactive Home Entertainment-(continued)** | **Interactive Home Entertainment-(continued)** | **Interactive Home Entertainment-(continued)** |
| Roblox Corp., Class A<sup>(b)</sup> | 116216 | &nbsp;&nbsp; $7642364 |
| Sea Ltd., ADR (Singapore)<sup>(b)</sup> | 74563 | &nbsp;&nbsp; 8685844 |
|  |  | &nbsp;&nbsp; 27276606 |
| **Interactive Media & Services-20.25%** | **Interactive Media & Services-20.25%** | **Interactive Media & Services-20.25%** |
| Alphabet, Inc., Class C | 176680 | &nbsp;&nbsp; 59811480 |
| Autohome, Inc., ADR (China) | 12008 | &nbsp;&nbsp; 264656 |
| Baidu, Inc., ADR (China)<sup>(b)(c)</sup> | 21643 | &nbsp;&nbsp; 3315275 |
| Bilibili, Inc., ADR (China)<sup>(b)(c)</sup> | 20891 | &nbsp;&nbsp; 711130 |
| Bumble, Inc., Class A<sup>(b)(c)</sup> | 20045 | &nbsp;&nbsp; 67151 |
| Cars.com, Inc.<sup>(b)(c)</sup> | 10629 | &nbsp;&nbsp; 120745 |
| Meta Platforms, Inc., Class A | 87253 | &nbsp;&nbsp; 62516774 |
| Pinterest, Inc., Class A<sup>(b)</sup> | 105740 | &nbsp;&nbsp; 2340026 |
| Reddit, Inc., Class A<sup>(b)</sup> | 24428 | &nbsp;&nbsp; 4403636 |
| Snap, Inc., Class A<sup>(b)</sup> | 260045 | &nbsp;&nbsp; 1802112 |
| TripAdvisor, Inc.<sup>(b)(c)</sup> | 20734 | &nbsp;&nbsp; 275555 |
| Yelp, Inc.<sup>(b)</sup> | 10954 | &nbsp;&nbsp; 299920 |
| Ziff Davis, Inc.<sup>(b)(c)</sup> | 7053 | &nbsp;&nbsp; 269566 |
|  |  | &nbsp;&nbsp; 136198026 |
| **Internet Services & Infrastructure-5.34%** | **Internet Services & Infrastructure-5.34%** | **Internet Services & Infrastructure-5.34%** |
| Akamai Technologies, Inc.<sup>(b)</sup> | 25577 | &nbsp;&nbsp; 2484806 |
| Fastly, Inc., Class A<sup>(b)(c)</sup> | 26549 | &nbsp;&nbsp; 245578 |
| GoDaddy, Inc., Class A<sup>(b)</sup> | 24025 | &nbsp;&nbsp; 2414993 |
| Okta, Inc.<sup>(b)(c)</sup> | 29884 | &nbsp;&nbsp; 2524600 |
| Shopify, Inc., Class A (Canada)<sup>(b)</sup> | 178285 | &nbsp;&nbsp; 23396340 |
| VeriSign, Inc. | 16404 | &nbsp;&nbsp; 4006349 |
| Wix.com Ltd. (Israel)<sup>(b)</sup> | 9758 | &nbsp;&nbsp; 847385 |
|  |  | &nbsp;&nbsp; 35920051 |
| **Movies & Entertainment-10.85%** | **Movies & Entertainment-10.85%** | **Movies & Entertainment-10.85%** |
| Netflix, Inc.<sup>(b)</sup> | 262851 | &nbsp;&nbsp; 21945430 |
| Roku, Inc., Class A<sup>(b)(c)</sup> | 23186 | &nbsp;&nbsp; 2207307 |
| Spotify Technology S.A. (Sweden)<sup>(b)</sup> | 36537 | &nbsp;&nbsp; 18281288 |
| Walt Disney Co. (The) | 270674 | &nbsp;&nbsp; 30532027 |
|  |  | &nbsp;&nbsp; 72966052 |
| **Other Specialty Retail-0.18%** | **Other Specialty Retail-0.18%** | **Other Specialty Retail-0.18%** |
| 1-800-Flowers.com, Inc., Class A<sup>(b)(c)</sup> | 6492 | &nbsp;&nbsp; 28045 |
| Chewy, Inc., Class A<sup>(b)</sup> | 39991 | &nbsp;&nbsp; 1164138 |
|  |  | &nbsp;&nbsp; 1192183 |
| **Passenger Ground Transportation-4.47%** | **Passenger Ground Transportation-4.47%** | **Passenger Ground Transportation-4.47%** |
| Grab Holdings Ltd., Class A (Singapore)<sup>(b)(c)</sup> | 703881 | &nbsp;&nbsp; 3026688 |
| Lyft, Inc., Class A<sup>(b)</sup> | 70904 | &nbsp;&nbsp; 1196151 |
| Uber Technologies, Inc.<sup>(b)</sup> | 323026 | &nbsp;&nbsp; 25858231 |
|  |  | &nbsp;&nbsp; 30081070 |
| **Real Estate Services-1.00%** | **Real Estate Services-1.00%** | **Real Estate Services-1.00%** |
| CoStar Group, Inc.<sup>(b)</sup> | 75284 | &nbsp;&nbsp; 4629966 |
| Zillow Group, Inc., Class C<sup>(b)</sup> | 33080 | &nbsp;&nbsp; 2085032 |
|  |  | &nbsp;&nbsp; 6714998 |
| **Restaurants-2.19%** | **Restaurants-2.19%** | **Restaurants-2.19%** |
| DoorDash, Inc., Class A<sup>(b)</sup> | 72137 | &nbsp;&nbsp; 14760673 |
| **Systems Software-7.49%** | **Systems Software-7.49%** | **Systems Software-7.49%** |
| GitLab, Inc., Class A<sup>(b)(c)</sup> | 26259 | &nbsp;&nbsp; 918540 |
| Microsoft Corp. | 114935 | &nbsp;&nbsp; 49455381 |
|  |  | &nbsp;&nbsp; 50373921 |
| **Technology Hardware, Storage & Peripherals-7.82%** | **Technology Hardware, Storage & Peripherals-7.82%** | **Technology Hardware, Storage & Peripherals-7.82%** |
| Apple, Inc. | 202826 | &nbsp;&nbsp; 52629291 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco NASDAQ Internet ETF (PNQI)—(continued)**

January 31, 2026

*(Unaudited)*

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Transaction & Payment Processing Services-1.36%** | **Transaction & Payment Processing Services-1.36%** | **Transaction & Payment Processing Services-1.36%** |
| Dlocal Ltd. (Uruguay) | 29461 | &nbsp;&nbsp; $396545 |
| PayPal Holdings, Inc. | 166067 | &nbsp;&nbsp; 8750070 |
|  |  | &nbsp;&nbsp; 9146615 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $540,154,505) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $540,154,505) | &nbsp;&nbsp; 672420609 |
| **Money Market Funds-0.05%** | **Money Market Funds-0.05%** | **Money Market Funds-0.05%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.61%<sup>(d)(e)</sup> <br>(Cost $348,411)<br>| 348411 | &nbsp;&nbsp; 348411 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.02% <br>(Cost $540,502,916) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-100.02% <br>(Cost $540,502,916) | &nbsp;&nbsp; 672769020 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** | **Investments Purchased with Cash Collateral** <br>**from Securities on Loan** |
| **Money Market Funds-4.79%** | **Money Market Funds-4.79%** | **Money Market Funds-4.79%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 3.65%<sup>(d)(e)(f)</sup><br>| 8823822 | &nbsp;&nbsp; $8823822 |
| Invesco Private Prime Fund, 3.80%<sup>(d)(e)(f)</sup> | 23379815 | &nbsp;&nbsp; 23386829 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $32,210,651) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $32,210,651) | &nbsp;&nbsp; 32210651 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-104.81% <br>(Cost $572,713,567) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-104.81% <br>(Cost $572,713,567) | &nbsp;&nbsp; 704979671 |
| OTHER ASSETS LESS LIABILITIES-(4.81)% | OTHER ASSETS LESS LIABILITIES-(4.81)% | &nbsp;&nbsp; (32366984)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $672612687 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Investment Abbreviations: <br> ADR -American Depositary Receipt

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at January 31, 2026. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the nine months ended January 31, 2026.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**April 30, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**January 31, 2026**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $160647 | &nbsp;&nbsp;&nbsp; $3287016 | &nbsp;&nbsp;&nbsp; $(3099252)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $348411 | &nbsp;&nbsp;&nbsp; $6278 |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; 16131440 | &nbsp;&nbsp;&nbsp; 147602962 | &nbsp;&nbsp;&nbsp; (154910580)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 8823822 | &nbsp;&nbsp;&nbsp; 322,828<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 41870189 | &nbsp;&nbsp;&nbsp; 336339570 | &nbsp;&nbsp;&nbsp; (354826729)<br>| &nbsp;&nbsp;&nbsp; 351 | &nbsp;&nbsp;&nbsp; 3448 | &nbsp;&nbsp;&nbsp; 23386829 | &nbsp;&nbsp;&nbsp; 876,919<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $58162276 | &nbsp;&nbsp;&nbsp; $487229548 | &nbsp;&nbsp;&nbsp; $(512836561)<br>| &nbsp;&nbsp;&nbsp; $351 | &nbsp;&nbsp;&nbsp; $3448 | &nbsp;&nbsp;&nbsp; $32559062 | &nbsp;&nbsp;&nbsp; $1206025 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of January 31, 2026. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

**Notes to Quarterly Schedules of Portfolio Holdings**

January 31, 2026

*(Unaudited)*

**NOTE 1—Additional Valuation Information**

Generally Accepted Accounting Principles ("GAAP") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under current market conditions. GAAP establishes a hierarchy that prioritizes the inputs to valuation methods, giving the highest priority to readily available unadjusted quoted prices in an active market for identical assets (Level 1) and the lowest priority to significant unobservable inputs (Level 3), generally when market prices are not readily available. Based on the valuation inputs, the securities or other investments are tiered into one of three levels. Changes in valuation methods may result in transfers in or out of an investment's assigned level:

Level 1 — Prices are determined using quoted prices in an active market for identical assets.

Level 2 — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants may use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, loss severities, default rates, discount rates, volatilities and others. When market movements occur after the close of the relevant foreign securities markets, foreign securities may be fair valued utilizing an independent pricing service.

Level 3 — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used. Unobservable inputs reflect Invesco Capital Management LLC's assumptions about the factors market participants would use in determining fair value of the securities or instruments and would be based on the best available information.

The following is a summary of the tiered valuation input levels, as of January 31, 2026. The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may materially differ from the value received upon actual sale of those investments.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| &nbsp;&nbsp; Invesco Dorsey Wright Basic Materials Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $90865432 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $90865432 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 186338 | &nbsp;&nbsp;&nbsp; 10672273 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 10858611 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $91051770 | &nbsp;&nbsp;&nbsp; $10672273 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $101724043 |
| &nbsp;&nbsp; Invesco Dorsey Wright Consumer Cyclicals Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $24665276 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $24665276 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 144741 | &nbsp;&nbsp;&nbsp; 2831904 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 2976645 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $24810017 | &nbsp;&nbsp;&nbsp; $2831904 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $27641921 |
| &nbsp;&nbsp; Invesco Dorsey Wright Consumer Staples Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $90392207 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $90392207 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 150302 | &nbsp;&nbsp;&nbsp; 8566360 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 8716662 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $90542509 | &nbsp;&nbsp;&nbsp; $8566360 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $99108869 |
| &nbsp;&nbsp; Invesco Dorsey Wright Energy Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $42394493 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $42394493 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 136009 | &nbsp;&nbsp;&nbsp; 5756266 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 5892275 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $42530502 | &nbsp;&nbsp;&nbsp; $5756266 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $48286768 |
| &nbsp;&nbsp; Invesco Dorsey Wright Financial Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $55852240 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $55852240 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 98449 | &nbsp;&nbsp;&nbsp; 3853102 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 3951551 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $55950689 | &nbsp;&nbsp;&nbsp; $3853102 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $59803791 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| &nbsp;&nbsp; Invesco Dorsey Wright Healthcare Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $121331511 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $121331511 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 162791 | &nbsp;&nbsp;&nbsp; 39022834 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 39185625 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $121494302 | &nbsp;&nbsp;&nbsp; $39022834 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $160517136 |
| &nbsp;&nbsp; Invesco Dorsey Wright Industrials Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $327782342 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $327782342 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 250354 | &nbsp;&nbsp;&nbsp; 39592891 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 39843245 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $328032696 | &nbsp;&nbsp;&nbsp; $39592891 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $367625587 |
| &nbsp;&nbsp; Invesco Dorsey Wright Technology Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $401153629 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $401153629 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 336939 | &nbsp;&nbsp;&nbsp; 60645904 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 60982843 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $401490568 | &nbsp;&nbsp;&nbsp; $60645904 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $462136472 |
| &nbsp;&nbsp; Invesco Dorsey Wright Utilities Momentum ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $49387861 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $49387861 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 122213 | &nbsp;&nbsp;&nbsp; 3117009 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 3239222 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $49510074 | &nbsp;&nbsp;&nbsp; $3117009 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $52627083 |
| &nbsp;&nbsp; Invesco NASDAQ Internet ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $672420609 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $672420609 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 348411 | &nbsp;&nbsp;&nbsp; 32210651 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 32559062 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $672769020 | &nbsp;&nbsp;&nbsp; $32210651 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $704979671 |

---

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-21265

- **c. CIK number of Registrant:** 0001209466

- **d. LEI of Registrant:** QPT4TMG79RF3UWNU0R52

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco Dorsey Wright Healthcare Momentum ETF

- **b. EDGAR series identifier (if any):** S000013104

- **c. LEI of Series:** 549300HW4X5F66JYEL71

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-04-30

- **b. Date as of which information is reported:** 2026-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $160526868.31

**Total Liabilities:** $39249889.65

**Net Assets:** $121276978.66

**Cash Not Reported:** $724.03

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000035320 | 11.56%               | -5.65%               | -2.79%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $91973.97                | $12950000.30                               |
| Month 2  | $999501.96               | $-8631402.86                               |
| Month 3  | $5987281.85              | $-9471932.67                               |

### Schedule of Portfolio Investments

| Name                                  | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Axsome Therapeutics, Inc.             | Axsome Therapeutics, Inc.                                  | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     19077 | NS      | $3514937.25   | 2.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals, Inc.       | Arrowhead Pharmaceuticals, Inc.                            | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |     73173 | NS      | $5073084.09   | 4.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals, Inc.        | Madrigal Pharmaceuticals, Inc.                             | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      5820 | NS      | $2847784.20   | 2.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Medpace Holdings, Inc.                | Medpace Holdings, Inc.                                     | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |      5853 | NS      | $3409255.44   | 2.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics, Inc.        | Protagonist Therapeutics, Inc.                             | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     28303 | NS      | $2315185.40   | 1.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphatec Holdings, Inc.               | Alphatec Holdings, Inc.                                    | CUSIP: 02081G201<br>LEI: 549300EZE8CQ8K65FS24 | Long             | EC               | CORP              | US        |     93325 | NS      | $1384009.75   | 1.14%             |  |  |  | No            |                  1 | On Loan: —       |
| AnaptysBio, Inc.                      | AnaptysBio, Inc.                                           | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |     17433 | NS      | $826498.53    | 0.68%             |  |  |  | No            |                  1 | On Loan: —       |
| Celcuity Inc.                         | Celcuity Inc.                                              | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |     31368 | NS      | $3432286.56   | 2.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Amneal Pharmaceuticals, Inc.          | Amneal Pharmaceuticals, Inc.                               | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |     95448 | NS      | $1305728.64   | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Replimune Group, Inc.                 | Replimune Group, Inc.                                      | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |    142365 | NS      | $1000825.95   | 0.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Guardant Health, Inc.                 | Guardant Health, Inc.                                      | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     47375 | NS      | $5402645.00   | 4.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Kodiak Sciences Inc.                  | Kodiak Sciences Inc.                                       | CUSIP: 50015M109<br>LEI: 254900IXI5NI8C9OQE24 | Long             | EC               | CORP              | US        |     49083 | NS      | $1117619.91   | 0.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Harrow, Inc.                          | Harrow, Inc.                                               | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48921 | NS      | $2002825.74   | 1.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Trevi Therapeutics, Inc.              | Trevi Therapeutics, Inc.                                   | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     95081 | NS      | $995498.07    | 0.82%             |  |  |  | No            |                  1 | On Loan: —       |
| IDEAYA Biosciences, Inc.              | IDEAYA Biosciences, Inc.                                   | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |     43358 | NS      | $1395694.02   | 1.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Stoke Therapeutics, Inc.              | Stoke Therapeutics, Inc.                                   | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |     73472 | NS      | $2229140.48   | 1.84%             |  |  |  | No            |                  1 | On Loan: —       |
| BridgeBio Pharma, Inc.                | BridgeBio Pharma, Inc.                                     | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     39428 | NS      | $3046601.56   | 2.51%             |  |  |  | No            |                  1 | On Loan: —       |
| Mirum Pharmaceuticals, Inc.           | Mirum Pharmaceuticals, Inc.                                | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |     17506 | NS      | $1806969.32   | 1.49%             |  |  |  | No            |                  1 | On Loan: —       |
| Phathom Pharmaceuticals, Inc.         | Phathom Pharmaceuticals, Inc.                              | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     64506 | NS      | $881797.02    | 0.73%             |  |  |  | No            |                  1 | On Loan: —       |
| Precigen, Inc.                        | Precigen, Inc.                                             | CUSIP: 74017N105<br>LEI: 549300XCWNQU35K64G19 | Long             | EC               | CORP              | US        |    254373 | NS      | $1142134.77   | 0.94%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcutis Biotherapeutics, Inc.         | Arcutis Biotherapeutics, Inc.                              | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     64211 | NS      | $1629033.07   | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines, Inc.            | Revolution Medicines, Inc.                                 | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |     41373 | NS      | $4011112.35   | 3.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio, Institutional Class | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |    162791 | NS      | $162791.30    | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Private Government Fund       | Invesco Private Government Fund                            | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  12272488 | NS      | $12272488.28  | 10.12%            |  |  |  | No            |                  2 | On Loan: No      |
| Relay Therapeutics, Inc.              | Relay Therapeutics, Inc.                                   | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     99689 | NS      | $763617.74    | 0.63%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Private Prime Fund            | Invesco Private Prime Fund                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  26750346 | NS      | $26750345.70  | 22.06%            |  |  |  | No            |                  2 | On Loan: No      |
| Annexon, Inc.                         | Annexon, Inc.                                              | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    149595 | NS      | $933472.80    | 0.77%             |  |  |  | No            |                  1 | On Loan: —       |
| Kymera Therapeutics, Inc.             | Kymera Therapeutics, Inc.                                  | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18557 | NS      | $1348908.33   | 1.11%             |  |  |  | No            |                  1 | On Loan: —       |
| Taysha Gene Therapies Inc.            | Taysha Gene Therapies Inc.                                 | CUSIP: 877619106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    367229 | NS      | $1656202.79   | 1.37%             |  |  |  | No            |                  1 | On Loan: —       |
| Immunome, Inc.                        | Immunome, Inc.                                             | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     75314 | NS      | $1854230.68   | 1.53%             |  |  |  | No            |                  1 | On Loan: —       |
| Cogent Biosciences, Inc.              | Cogent Biosciences, Inc.                                   | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     76829 | NS      | $2758929.39   | 2.27%             |  |  |  | No            |                  1 | On Loan: —       |
| Tarsus Pharmaceuticals, Inc.          | Tarsus Pharmaceuticals, Inc.                               | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21290 | NS      | $1374056.60   | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics, Inc.            | Travere Therapeutics, Inc.                                 | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     80167 | NS      | $2492392.03   | 2.06%             |  |  |  | No            |                  1 | On Loan: —       |
| EyePoint, Inc.                        | EyePoint, Inc.                                             | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |     45221 | NS      | $611387.92    | 0.50%             |  |  |  | No            |                  1 | On Loan: —       |
| Terns Pharmaceuticals, Inc.           | Terns Pharmaceuticals, Inc.                                | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |    146784 | NS      | $5078726.40   | 4.19%             |  |  |  | No            |                  1 | On Loan: —       |
| Alignment Healthcare, Inc.            | Alignment Healthcare, Inc.                                 | CUSIP: 01625V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     94994 | NS      | $2140214.82   | 1.76%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp.             | United Therapeutics Corp.                                  | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      6607 | NS      | $3101920.43   | 2.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc.                     | Nuvation Bio Inc.                                          | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    270074 | NS      | $1415187.76   | 1.17%             |  |  |  | No            |                  1 | On Loan: —       |
| Monte Rosa Therapeutics, Inc.         | Monte Rosa Therapeutics, Inc.                              | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51721 | NS      | $1061314.92   | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd.                 | Roivant Sciences Ltd.                                      | CUSIP: G76279101<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |    237985 | NS      | $5145235.70   | 4.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc.                        | Zymeworks Inc.                                             | CUSIP: 98985Y108<br>LEI: 894500AHOYAGYLYZJL67 | Long             | EC               | CORP              | US        |     36225 | NS      | $816149.25    | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Fortrea Holdings Inc.                 | Fortrea Holdings Inc.                                      | CUSIP: 34965K107<br>LEI: 5493000FIVFABOVCDU97 | Long             | EC               | CORP              | US        |     46232 | NS      | $777159.92    | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Healthcare, Inc.                  | HCA Healthcare, Inc.                                       | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |      7064 | NS      | $3449139.28   | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Lexeo Therapeutics, Inc.              | Lexeo Therapeutics, Inc.                                   | CUSIP: 52886X107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    100460 | NS      | $744408.60    | 0.61%             |  |  |  | No            |                  1 | On Loan: —       |
| Praxis Precision Medicines, Inc.      | Praxis Precision Medicines, Inc.                           | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20476 | NS      | $6429464.00   | 5.30%             |  |  |  | No            |                  1 | On Loan: —       |
| BrightSpring Health Services, Inc.    | BrightSpring Health Services, Inc.                         | CUSIP: 10950A106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     58168 | NS      | $2284257.36   | 1.88%             |  |  |  | No            |                  1 | On Loan: —       |
| PACS Group, Inc.                      | PACS Group, Inc.                                           | CUSIP: 69380Q107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     57608 | NS      | $1944846.08   | 1.60%             |  |  |  | No            |                  1 | On Loan: —       |
| Oruka Therapeutics, Inc.              | Oruka Therapeutics, Inc.                                   | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |     28102 | NS      | $961931.46    | 0.79%             |  |  |  | No            |                  1 | On Loan: —       |
| Zenas Biopharma, Inc.                 | Zenas Biopharma, Inc.                                      | CUSIP: 98937L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29559 | NS      | $542998.83    | 0.45%             |  |  |  | No            |                  1 | On Loan: —       |
| Upstream Bio, Inc.                    | Upstream Bio, Inc.                                         | CUSIP: 91678A107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     31208 | NS      | $969944.64    | 0.80%             |  |  |  | No            |                  1 | On Loan: —       |
| Palvella Therapeutics, Inc.           | Palvella Therapeutics, Inc.                                | CUSIP: 697947109<br>LEI: 254900AJDH8PAOOI5T33 | Long             | EC               | CORP              | US        |     13210 | NS      | $1013074.90   | 0.84%             |  |  |  | No            |                  1 | On Loan: —       |
| Maze Therapeutics, Inc.               | Maze Therapeutics, Inc.                                    | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23056 | NS      | $1004780.48   | 0.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Sionna Therapeutics, Inc.             | Sionna Therapeutics, Inc.                                  | CUSIP: 829401108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23894 | NS      | $1009760.44   | 0.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Ensign Group, Inc. (The)              | Ensign Group, Inc. (The)                                   | CUSIP: 29358P101<br>LEI: 5493003K4HEEA8Q0BC72 | Long             | EC               | CORP              | US        |     13319 | NS      | $2286339.54   | 1.89%             |  |  |  | No            |                  1 | On Loan: No      |
| RAPT Therapeutics, Inc.               | RAPT Therapeutics, Inc.                                    | CUSIP: 75382E208<br>LEI: 549300MB473BIU78ES48 | Long             | EC               | CORP              | US        |     27749 | NS      | $1600562.32   | 1.32%             |  |  |  | No            |                  1 | On Loan: —       |
| Tenet Healthcare Corp.                | Tenet Healthcare Corp.                                     | CUSIP: 88033G407<br>LEI: 0W9AIBT6U6ADJ2I8HK17 | Long             | EC               | CORP              | US        |     19008 | NS      | $3597834.24   | 2.97%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics, Inc.                | PTC Therapeutics, Inc.                                     | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |     21303 | NS      | $1609015.59   | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Axogen, Inc.                          | Axogen, Inc.                                               | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36410 | NS      | $1268888.50   | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc.           | Ligand Pharmaceuticals Inc.                                | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      7514 | NS      | $1443439.40   | 1.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Artivion, Inc.                        | Artivion, Inc.                                             | CUSIP: 228903100<br>LEI: 549300YTKV8DMSMG6K81 | Long             | EC               | CORP              | US        |     18790 | NS      | $766068.30    | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera, Inc.                          | Natera, Inc.                                               | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |     18625 | NS      | $4304982.50   | 3.55%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-02

**Name of Applicant:** Invesco Exchange-Traded Fund Trust

**Signature:** Adrien Deberghes

**Name of Signer:** Adrien Deberghes

**Title:** Vice President